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Exacerbations of chronic obstructive pulmonary disease (COPD) compose a considerable 
burden for both patients and health care systems. Optimal management in primary care, 
including self-treatment of COPD exacerbations with antibiotics and oral corticosteroids, is 
considered to be one key for providing good care for patients at reasonable costs. This thesis 
aimed to explore treatment of COPD exacerbations with antibiotics and/or oral corticosteroids 
and hospitalization from different primary care perspectives, e.g. guidelines, general 
practitioners and patients.  
A systematic review of treatment criteria for antibiotics and oral corticosteroids in national 
and international COPD guidelines, and an assessment of the underlying evidence for these 
recommendations composed the first part of the project. The results showed that the 
recommended treatment criteria were mostly based on respiratory symptoms, and that the 
studies the recommendations are based on are often conducted with patients that are not 
representative for a primary care setting. The second study explored COPD patients’ 
perspective on self-treatment with antibiotics and oral corticosteroids through a thematic 
analysis of 12 semi-structured in-depths interviews. We found that concerns with the 
medications’ adverse effects play a key role in CODD patients’ decisions to initiate self-
treatment with antibiotics and/or oral corticosteroids. The nature of the patient-physician 
relationship including the patients’ understanding of legitimacy to seek help is important to 
their help seeking behaviour when feeling insecure about the need for treatment or in case of 
treatment failure. The third study investigated GPs’ accounts of their decision-making 
regarding treatment with antibiotics and oral corticosteroids and hospitalization through a 
thematic analysis of seven focus group discussions. The results show that one main driver of 
GPs’ decision-making are worries about having overlooked a severe underlying illness. GPs 
consider at holistic understanding of illness and the patients’ own experiential knowledge 
important to make reasonable decisions for the individual patient under medical uncertainty. 
Moreover, GPs’ decisions depend on the availability and reliability of other formal and 
informal carers, and the healthcare systems’ organization and sociocultural ‘code of conduct’. 
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Overall, the findings of this thesis support an integrative and collaborative approach to 
management of COPD exacerbations. The heterogeneous, versatile and often individualized 
nature of COPD exacerbations requires a flexible framework to decision-making that 
integrates both medical knowledge and other types of knowledge that are grounded in human 
experience and relationships. Such an integrative understanding of knowledge may guide 
future clinical research and guideline development in considering primary care evidence and 
expertise from primary care stakeholders and patients to a larger extent, and may also 
facilitate collaborative management of COPD exacerbations that allows for sharing expertise 





Forverringer av kronisk obstruktiv lungesykdom (KOLS) er en betydelig byrde for pasienter 
og helsesystemer. Optimal behandling av KOLS forverringer i primærhelsetjenesten, 
inkludert egenbehandling med antibiotika og orale kortikosteroider, ansees som meget viktig 
for å sikre god behandling og samtidig redusere den økonomiske byrden. Denne avhandlingen 
ønsker å øke kunnskapen om behandling av KOLS pasienter med eksaserbasjoner i 
primærhelsetjenesten ved å utforske tre forskjellige perspektiver (retningslinjer, pasienter og 
allmennleger) på dette fenomenet. 
 
Denne avhandlingen er basert på tre studier. Første studie er en systematisk review av 
behandlingskriterier for antibiotika og orale kortikosteroider i nasjonale og internasjonale 
KOLS retningslinjer og en kritisk evaluering av evidensen som anbefalingene er basert på. 
Resultatene viser at behandlingskritene er hovedsakelig basert på respiratoriske symptomer og 
at evidensen er i lite grad overførbar til en primærhelsetjenestekontekst. I den andre studien 
ble KOLS pasienters erfaringer med egenbehandling utforsket ved tematisk analyse av 12 
semi-strukturerte dybde-intervjuer. Hovedfunnene viser at bekymringer for medisinenes 
bivirkninger spiller en viktig rolle i pasientens beslutninger angående behandlingsstart, og at 
lege-pasient forholdet inkludert pasientens forståelse av eget ansvar for behandlingen kan 
påvirke i stor grad om og når pasienter søker hjelp ved usikkerhet eller når behandlingen ikke 
virker. Målet for den tredje studien var å utforske allmennlegers beslutninger på behandling 
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av KOLS eksaserbasjoner med antibiotika og orale kortikosteroider, og innleggelser, ved 
tematisk analyse av 7 fokusgruppeintervjuer fra forskjellige europeiske land og Hongkong. 
Hovedfunnene viser at usikkerhet og redsel for å ha oversett alvorlig sykdom er sterke 
pådrivere i allmennlegers beslutninger. Allmennlegene syntes at en holistisk forståelse av 
sykdommen og å involvere pasienters erfaringsbasert kunnskap i beslutningene er viktig for 
adekvat behandling av den enkelte pasienten. 
 
Samlet støtter resultatene av de tre studiene integrativ og samhandlingsbasert behandling av 
KOLS pasienter med eksaserbasjoner. De heterogene, komplekse og ofte individualiserte 
KOLS eksaserbasjoner krever en fleksibel ramme for beslutninger som integrerer både 
biomedisinsk kunnskap og andre typer kunnskap som er basert på menneskers erfaring og 
relasjoner. En slik integrativ forståelse av kunnskap vil kunne guide fremtidig klinisk 
forskning og utvikling av retningslinjer i å ta større hensyn til medisinsk kunnskap og 
ekspertise fra primærhelsetjenesten og pasienter, og vil også kunne fremme samhandling 
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1.1 Personal and professional background  
According to a skilled Norwegian qualitative researcher and professor of family medicine, 
Kirsti Malterud, engaging in a research project can be compared to going on a journey 1. She 
wrote that the baggage we carry mirrors our assumptions and understandings that influence 
the way we proceed on our journey - e.g. how we collect and read our data1. In addition to 
personal and professional experiences, we carry a certain worldview and understanding of 
knowledge in our ‘baggage’, which will inevitably influence our motivations and our choices 
along the way. Being aware of this ‘baggage’ and making it transparent for the reader is 
therefore a key to producing and sharing research in a credible, valid and responsible way1. 
Hence, I will first introduce the reader to my personal and professional background and my 
theoretical approach to this research project. 
I started to engage in research in April 2012 as a research assistant in the General 
Practice Research Unit at UiT The Arctic University of Norway after having finished my 
medical studies in Germany. During my time as a research assistant, I translated transcripts of 
focus group discussions (FGD) (not knowing that they would later on become part of my own 
project), which gave me a first taste of qualitative methods as well as on research on chronic 
obstructive pulmonary disease (COPD). Furthermore, I collected information about the 
healthcare systems in which the FGDs had taken place. I was not particularly interested in 
COPD, but had quite some experience (at least from the point of view of a doctor just having 
finished medical school) with this patient group from my internships at a pulmonology 
department in Germany. During a calmer period at work, I started to read more about COPD 
and issues that may complicate the management of exacerbations. I felt sort of honoured 
when I was then asked to start a PhD project. The PhD project was and is part of the 
international research project “Caring for adult patients with acute exacerbations of asthma or 
COPD in general practice” (PEXACO), which was initiated by Hasse Melbye and conducted 
in collaboration with research groups from six European countries and Hong Kong. PEXACO 
consists of both epidemiological studies and qualitative interview studies, the latter projects 
being led by Mette Bech Risør. 
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The opportunity to combine research with clinical work as general practitioner (GP) trainee 
was important to me to not loose contact to patients and clinical practice. Throughout the 
years, I learned to enjoy the reflective nature of research as counterbalance to rather hectic 
days in general practice. When starting working as a GP, I realized that practicing medicine 
was different from studying medicine in medical school. Instead of dealing with diseases, I 
had to deal with people. Instead of solving cases in classrooms and typically coming up with a 
conclusion on how to solve the problem, I needed to learn to deal with the uncertainty of ‘real 
world’ clinical practice. I recognized quickly that medical theoretical knowledge was worth 
little without the ability to use it in a specific context.  
These experiences have truly influenced the way I approached this research project. 
Particularly, I carried with me the experienced gap between theoretical, ‘textbook’ medicine 
and how medicine is practiced in a ‘real world’ setting. I found my own experiences reflected 
in literature addressing problems in COPD care and in criticisms of evidence-based medicine 
(EBM). As a result, my interest in what else than evidence and guidelines is relevant to a 
persons’ decision-making grew. 
  
 
1.2 Literature review 
1.2.1 Chronic obstructive pulmonary disease - an overview 
COPD is a chronic lung disease characterized by persistent, typically progressive, airflow 
limitation. COPD is associated with an enhanced chronic inflammatory response in the 
airways to noxious particles or gases. Typical symptoms of COPD include dyspnoea, chronic 
cough and chronic sputum production, but spirometry detected persistent airflow limitation 
(post-bronchodilator forced expiratory volume in 1 second (FEV1)/forced vital capacity 
(FVC) < 0.7) is required to establish the clinical diagnosis2. COPD has been, and will be, a 
considerable public health problem worldwide. Globally, about 328 Million people are 
estimated to suffer from COPD, which is 4.77% of the world population3. It is one of the 
major leading causes of death worldwide4. The major risk factor is tobacco smoking, but 
occupational exposure, air pollution and individual predisposition also play an important 
role3. There is a geographic variety of risk factors, prevalence, mortality and burden of 
illness5. In Europe and North America, people with COPD now live longer than two decades 
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ago, however, the quality of life during these years may be diminished due to the illnesses 
impact on daily living3,4,6,7. COPD is associated with high comorbidity from all organ 
systems, including anxiety and depression8. Yet, respiratory illnesses such as asthma and 
pulmonary vascular disease, and cardiovascular illnesses such as ischemic heart disease, 
congestive heart failure and arrhythmias, are the most prevalent comorbidities9. In addition to 
negative impact on patients’ quality of life, COPD accounts for a high societal burden with a 
considerable economic impact on health care systems. Costs increase with COPD severity, 
prevalence of comorbidity and with inpatient treatment. Exacerbations of COPD are the major 
cause of hospitalizations and driver for inpatient treatment expenditure10,11.  
 
1.2.2 Exacerbations of COPD 
COPD exacerbations are defined by the Global Initiative for Chronic Obstructive Lung 
disease2 as “an acute event characterized by a worsening of the patient’s respiratory 
symptoms that is beyond normal day-to-day variations and leads to a change in medication”2. 
Another consensus definition is slightly broader and acknowledges associated non-respiratory 
clinical descriptors (such as increased heart rate, or fatigue): e.g., a COPD exacerbation is “a 
sustained worsening of the patient's condition, from the stable state and beyond normal day-
to-day variations, necessitating a change in regular medication in a patient with underlying 
COPD”12. COPD patients experience approximately one or two exacerbations per year, with 
increasing frequency in the later stages of the illness. Yet, epidemiological data indicate that a 
subgroup of patients, the “frequent exacerbators”, may be particularly susceptible to 
exacerbations regardless of disease severity13,14. In the long-term, COPD exacerbations have 
been found associated with accelerated decline in lung function and progressive decline of the 
overall health status15,16. Exacerbations have a negative impact on the personal and societal 
level, both short-term and long-term. The symptoms’ impact on the patients’ daily living 
impair their health related quality of life and exercise capacity. In severe cases, reduced 
exercise capacity may mean being housebound or being in need of assistance with daily tasks, 
which again may reduce the patients’ feeling of well-being15-18. At the societal level, COPD 
exacerbations stand for a great economic burden. In addition to direct costs from inpatient 
treatment, loss of workdays and long-term impact on the patients’ health status compose a 




COPD exacerbations are heterogeneous in terms of aetiology, clinical manifestation and 
treatment requirements. Their main cause are assumed to be bacterial and viral infections, but 
non-infectious factors, such as air pollution and meteorological effects also play a role. The 
overall cause, however, may be multifactorial, and especially the role of systemic 
inflammation and of comorbidities is not yet fully understood15,16. The clinical manifestation 
is typically characterised by increased cough, dyspnoea and sputum volume and purulence, 
but systemic responses such as fatigue and simultaneous exacerbation of comorbidities such 
as heart failure are common12. COPD exacerbations may require different kinds of treatments 
on all levels of the healthcare system12. 
 
1.2.3 Management of COPD exacerbations: treatment options and guidelines 
COPD exacerbations may be treated in a primary or secondary care setting, depending for 
instance on the exacerbation’s severity, frequency of exacerbations and comorbidity12. The 
goal of managing a COPD exacerbation has been summarized to “minimize the impact of the 
current exacerbation and prevent the development of subsequent exacerbations”19. Based on 
previous literature13,20,21, the GOLD committee estimated that 80% of exacerbations can be 
managed in an outpatient setting2. There are three principle pharmacological treatment 
options, short-acting bronchodilators, antibiotics and oral corticosteroids2. Short-acting 
bronchodilators, such as beta-agonists or anticholinergic agents are the first line treatment of 
airflow obstruction and symptoms during exacerbations. Antibiotics and/or oral 
corticosteroids should be added when there is an expected benefit for the patient2. The 
expected benefit, however, is apparently greater for patients with severe exacerbations treated 
in a hospital setting. Patients treated in primary care have mainly mild to moderate 
exacerbations, for which the effect of antibiotics and oral corticosteroids remains 
controversial2,19,22,23. Due to potential disadvantages of either treatment, particularly side 
effects of oral corticosteroids23 and the risk of bacterial resistance development from 
unnecessary antibiotic use24, patients should be carefully assessed before initiating treatment.  
 
In the latest GOLD guidelines, it is stated that “the assessment of an exacerbation is 
based on the patient’s medical history and clinical signs of severity and some laboratory tests, 
if available”, specifying that “spirometry is not recommended during an exacerbation because 
it can be difficult to perform and measurements are not accurate enough”2. Symptoms such as 
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increased dyspnoea and clinical signs such as changes in sputum play a major role in the 
assessment of COPD exacerbations since Anthonisen’s landmark trial published in 198725. 
Since then, increased dyspnoea, increased amount of sputum, and increased purulence of 
sputum are regarded as the cardinal symptoms of COPD exacerbations. Anthonisen et al. 
recommended that antibiotic treatment was only justified in the presence of more than one of 
these symptoms25. Still today, in the current GOLD guidelines, recommendations on 
antibiotic treatment for COPD exacerbations are based on the presence of these symptoms, 
yet with emphasis on sputum purulence2. Even though studies have shown the usefulness of 
CRP testing to reduce antibiotic prescribing26,27, it is not recommended in the GOLD 
guidelines - as opposed to, for instance, the Norwegian COPD guidelines2,28. The Dutch 
guidelines do not only base their recommendations on sputum changes, but reserve antibiotic 
treatment for patients with poor lung function and other risk factors for a severe disease 
course29. Recommended diagnostic tests for the assessment of COPD exacerbations in the 
GOLD guidelines include pulse oximetry, chest radiography, electrocardiogram and several 
blood tests, and recommendations for hospitalizations are solely based on clinical signs that 
indicate severe respiratory problems (e.g. cyanosis, resting dyspnoea) and on signs for high 
vulnerability (older age, frequent exacerbations, severe underlying COPD, insufficient home 
support)2. We do not know exactly to which degree COPD guidelines are followed in primary 
care, but concerns about implementation of COPD guidelines indicate that primary care 
physicians may not follow guidelines very closely30,31. Perceived inapplicability is one of 
many possible barriers to adherence, which can also vary largely within and between 
guidelines30,32-34.  
 
1.2.4 Management of COPD exacerbations in clinical practice 
Studies from various countries on management of COPD exacerbations show high 
hospitalization rates and great variations in prescribing antibiotics and/or oral 
corticosteroids26,35-41. In terms of assessment and decision-making for treatment, several 
predictors for prescribing have been identified in clinical studies. Especially purulent sputum 
and raised CRP values seem strongly associated with the decision to prescribe antibiotics, but 
also chest findings or decreased oxygen for both antibiotics and oral corticosteroids26,41. 
Studies on antibiotic prescribing for cough, respiratory infections and lower respiratory tract 
infections show comparable results42-44. Overall, it seems as if CRP testing decreases the 
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emphasis laid on symptoms and clinical findings for prescribing antibiotics in COPD 
exacerbations and other respiratory illnesses, and that CRP testing is protective against 
antibiotic use. Predictors for prescribing oral corticosteroids for COPD exacerbations are not 
investigated to a comparable extent. Al-Ani et al. described that, similar to antibiotics, 
abnormal chest findings, raised CRP values and decreased oxygen saturation were the 
strongest predictors for prescribing41.  
 
Prescribing behaviour, however, is complex and a variety of interrelated intrinsic and 
extrinsic factors influence prescribing. A considerable body of evidence exists that addresses 
GPs’ prescribing practices, mostly regarding antibiotic prescribing for a variety of conditions. 
Signs and symptoms present at the time of prescribing seem indeed important factors, as well 
as comorbidity and allergies. Factors relating to clinicians’ themselves - such as complacency, 
fear of complications, the relationship with the patient, problems with communication and 
peer influence – as well as healthcare system-related factors - such as time pressure, 
organizational models and lack of resources – also play a role in clinicians’ management 
decisions45-50.  
 
1.2.5 Self-treatment of COPD exacerbations 
In addition to choosing the right treatment, initiating it early is important to prevent a severe 
disease course and to minimize its burden51. Therefore, it is of concern that COPD patients 
may delay help seeking or not seek help at all52-55. Self-treatment of COPD exacerbations has 
emerged during the last decade as a new concept to tackle the high burden of COPD 
exacerbations for patients and society as a result from delay in treatment onset56. The 
underlying idea is that patients receive ‘standby’ antibiotics and/or oral corticosteroids to 
promptly start treatment when certain symptom changes occur. Self-treatment of 
exacerbations is often central part of the much more comprehensive care concept ‘self-
management’. The latter is based on the chronic care model of disease management, which 
draws on self-regulation theories and the concept of ‘self-efficacy’57,58. Cornerstones for self-
management programs or interventions are pulmonary rehabilitation, approaches targeting 
knowledge development, social support, web-based interventions and knowledge and 
attitudes of healthcare professionals, all of which should empower patients to confidently 
manage their illness and engage in collaboration with healthcare professionals59. More 
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specifically, self-management in COPD encompasses smoking cessation, physical activity, 
nutrition, medication adherence, and coping skills in addition to self-treatment of 
exacerbations60. As Nici stated in 2014, self-management and self-treatment of COPD and its 
exacerbations composes “a splendid concept”61 to help patients gaining knowledge and skills 
that are necessary to achieve optimal outcomes. However, so far, the efficacy of self-
management interventions are not convincing. One issue concerning research on efficacy is 
that self-management interventions vary in design, and trials in methodology58, another is that 
results of these trials are contradictory. In 2000, Gallefoss found that giving COPD patients 
with inhaled corticosteroids oral corticosteroids on standby reduced the number of GP visits 
the following year and increased the patients’ health-related quality of life62. Bourbeau’s and 
Rice’s trials in 2003 and 2010, respectively, showed reduced COPD-related and all-cause 
hospitalization rates and emergency room visits and increased health statuses in the 
intervention groups63,64. Four studies between 2007 and 2012 could not confirm these 
findings. Beaulieu-Genest observed increased use of both antibiotics and oral corticosteroids 
but no reduction in unplanned medical visits65. Bucknall et al. reported no differences in 
admission and death rates66 and Bischoff no improved health related quality of life in the 
intervention groups67. Moreover, Fan’s trial had to be stopped prematurely due to increased 
mortality rates in the self-management group68. The reasons for these undesired courses 
remain unknown. It might be that not all participants were able to decide whether antibiotics 
and/or steroids were the right type of treatment for their symptoms, and, as Nici argued, some 
may have needed an assessment by a physician61. Bischoff’s analysis would fit such a 
hypothesis. He found that patients who actually use the medication and successfully treat 
themselves may in fact achieve benefits, but that, at least in his trials, only 40% actually 
adhered to the self-treatment plans as intended by the researchers67,69.  
 
Both healthcare professionals’ and patients’ opinion about the idea of self-treatment of 
exacerbations seems predominantly positive70,71. Yet, healthcare professionals may be 
concerned that self-treatment does not fit all patients, that patients should be carefully chosen 
(by disease severity and previous behaviour), and that giving sufficient education may be 




1.3 Challenges and gaps of knowledge 
 
Considering the body of evidence and state of knowledge so far, I will point to three main – 
though interrelated - aspects that emerge as challenges and/or gaps of knowledge.  
 
1.3.1 Challenges regarding primary care of COPD exacerbations 
1.3.1.1 The complexity of diagnosing and decision-making 
The first aspect relates to the fact that the debate about the management of COPD 
exacerbations is not uniform, i.e. that it starts at different points in the diagnostic process and 
that it varies in the degree to which the complexity of decision-making and health and illness 
behaviour is taken into account. Care policies and guidelines are, for instance, concerned with 
the management of a diagnosis, the ‘disease’ COPD exacerbation. Also, observational studies 
that aim to identify predictors for treatment, calculate their results on the basis of the 
diagnosis ‘COPD exacerbation’. However, this disease-oriented approach to management 
does not consider that, for patients and GPs, decision-making about self-treatment, help 
seeking, prescribing and hospitalization rather starts with experiencing symptoms/symptom 
changes and the patients’ story, respectively. Particularly management decisions in primary 
care are often based on symptom patterns instead of a diagnosis72. Moreover, due to the 
complex etiological and pathophysiological pathways and mechanism underlying COPD 
exacerbations, it may often be impossible to make a clear diagnosis. As Beghé wrote in the 
European Respiratory Journal in 2013: “Exacerbations of respiratory symptoms in COPD 
patients may not be exacerbations of COPD”73, but can express different underlying diseases 
74. Overall, however, even though when making a clear diagnosis is possible, we know that 
medical decision-making and patients’ health and illness behaviour, respectively, are 
complex. These processes can be influenced by a variety of contextual, cognitive and 
emotional factors and may take place on both a conscious and subconscious level75-78. 
 
1.3.1.2 Self-treatment behaviour as response to illness experience 
The second aspect relates to a comparable issue, yet concerning self-treatment. Even though 
based on symptom recognition and not on a clinical diagnosis as such, self-treatment plans as 
described in the literature do not acknowledge that symptoms may not present ‘textbook’ like, 
but can be diffuse and slowly developing over a couple of days79,80. Even though these 
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symptoms may in fact indicate a COPD exacerbation and the need for treatment, the slow 
development of symptoms may hamper the determination of the adequate point of time for 
starting treatment. In this regard, it is useful to refer to the important distinction between 
‘disease’ and ‘illness’ and the implications for patients’ self-treatment behaviour. While 
‘disease’ refers to abnormalities of the structure and function of body organs and systems, 
‘illness’ refers to a person’s experience of ill-health and the meaning given to that 
experience81. From this perspective, when COPD patients respond to symptoms, they do not 
respond to the biomedical, pathophysiological changes causing the symptoms, but to how 
their body and mind react to these changes. Therefore, as Helman wrote in 1981, “the 
disease/illness model (…) provides a useful perspective on the treatment of ill-health in 
general practice and on such phenomena as non-compliance, self-medication and 
dissatisfaction with medical care. (…)81. Self-regulatory models, such as Leventhal’s 
Common Sense Model of Illness Representation82 are based on this distinction, which is in 
fact brought up as theoretical framework in the self-management literature83. The Common 
Sense Model of Illness Representation82 proposes that a person’s response to ill health is 
based on cognitive representations of the particular health threat, informed by concrete or 
abstract information, beliefs and experiences. As Nici writes: “It’s one thing to have an action 
plan and to convey this information to the patient; it’s another matter to have the patient 
actually put it into practice.”61. In other words, it would be naïve to believe that a patient’s 
initiation of self-treatment is solely based on an objective evaluation of symptoms according 
to medical knowledge. In addition to education58,84,85, motivation, believe in treatment, self-
efficacy, psychological health and the patient-provider relationship may COPD patients’ self-
management behaviour86-89. 
 
1.3.1.3 Organizational and relational aspects of healthcare 
The third aspect relates to care on the interface of different sectors and levels of healthcare 
systems, particularly in terms of sharing care between involved actors, role identification, the 
scope of responsibility and power relations. Healthcare can be divided into different levels, 
such as primary care, secondary and tertiary care90, as well as into the type of healthcare 
provided. In Kleinman’s model of health care sectors, for instance, healthcare systems consist 
of three sectors, a popular, professional and folk sector91. All of these can be found within the 
primary care level, where they overlap and interconnect. I would regard the phenomenon of 
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‘self-treatment of COPD exacerbations’ to take place in between the popular and the 
professional sector. GPs are principally part of the professional sector in primary care, but 
their practice touches both the popular and folk sectors as well as they collaborate with 
professionals on the secondary care level. Understanding the mechanisms and factors that 
influence the social actors’ behaviour and decision-making on the boundaries of these sectors 
and levels seems highly relevant to understanding how COPD exacerbations are managed in 
primary care, especially hospitalization and self-treatment as alternative/supplement to 
traditional health seeking. Moreover, the relationship, including power relations, between 
actors in different sectors may play a role to decisions made at the boundaries, or even within, 
sectors and levels of healthcare organization. For instance, the overall relationship between 
patients and physicians/healthcare professionals can be assumed to have undergone changes 
during the last decades, from an overweight of a paternalistic relation to more patient 
empowerment and patient involvement92.  
 
1.3.2 Gaps of knowledge 
As described above (see Literature review), the overall care goals for COPD exacerbations 
are to reduce mortality, morbidity and health costs and to improve patients’ self-management 
abilities and quality of life. Much focus is, and has been, on the prevention of exacerbations to 
reduce hospitalization rates through pulmonary rehabilitation and self-management under 
stable state. This is of course positive, but similarly important is to improve management of 
exacerbations when actually happening. So far, research has mainly focused on the effects of 
medical treatments and of self-treatment interventions on disease progression, morbidity and 
mortality rates, healthcare utilization, health related quality of life and cost-effectiveness and 
on symptoms, clinical signs and diagnostic tests as predictors for treatment (see Literature 
review). There are a number of studies addressing COPD patients’ perspectives on COPD 
exacerbations79,80,93,94, how they experience helplessness under an exacerbations95 and their 
attitudes towards self-treatment70. None of these studies, however, explicitly focus on self-
treatment as such, and only some patients in Williams et al.’s study seem to have used stand-
by medications94. There is one qualitative study investigating the patients’ perspective of a 
comprehensive self-management program including self-treatment of exacerbations89. 
Findings show that most patients appreciated the opportunity for self-treatment, particularly 
for the possibility to start early, for autonomy and for not having to call a doctor. Moreover, 
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the frequent follow-up visits and 24 hours access to the hospital seemed important to create a 
feeling of safety among the participants. Overall, the authors reported increased self-
confidence and coping behaviour among the participants of the self-management 
programme89. Despite these rather positive findings, it is questionable whether they are 
transferrable to COPD patients who receive self-treatment medications in regular care, with 
no trial programs providing close follow-ups. We do not know to which extent COPD patients 
receive antibiotics and/or oral corticosteroids for self-treatment, and how they are instructed 
in using the medications. Yet, it is indicated in for instance Davies’ et al.’s study that there is 
a wide variation in reported use of self-treatment and that GPs carefully select patients for 
self-treatment71. A Canadian survey found that only 34% of COPD patients had received a 
written action plan96. We do not know what the respective patients think about their self-
treatment opportunity and how they make use of it. Regarding help seeking of COPD 
patients, there is some evidence showing that not only symptom severity, but also access to 
care, nature and quality of the patient-provider relationship and the perception of 
stigmatization during prior healthcare encounters influence patients’ decision to consult a 
healthcare professional79,97. Even though these studies are probably to a certain extent 
transferable to the group of COPD patients who have received antibiotics and/or oral 
corticosteroids in routine care, we do not know how the self-treatment possibility relates to 
these patients’ help seeking.  
Regarding GPs’ management decisions for COPD patients with exacerbations, the study 
of Risør et al. from the PEXACO group gives some insight. The authors found that the 
clinical complexity of multimorbidity and the various contextual elements related to patients’ 
social circumstances made decision-making complicated. The authors concluded that “GPs 
and respiratory physicians balance these concerns with medical knowledge and practical, 
situational knowledge, trying to encompass the complexity of a medical condition.”98. Yet, 
from this study, it remains unclear what in particular GPs consider relevant to their decisions 
to prescribe antibiotics and/or oral corticosteroids and to hospitalize patients. 
 
2 Research questions 
The overall aim of this project was to investigate the management of COPD exacerbations in 
primary care and to hopefully discover aspects that may further develop primary care for 
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COPD patients with exacerbations. The project has particular interest in how the key actors of 
managing COPD exacerbations, i.e. GPs and COPD patients, assess symptoms and make 
decisions regarding treatment with antibiotics, oral corticosteroids, hospitalization and help 
seeking. 
 
The specific aims of the three studies were 
 To assess how COPD exacerbations should be treated according to national and 
international COPD guidelines, and to assess the underlying evidence of the 
recommendations in terms of applicability to a primary care setting.  
 
 To get insight into the patients’ perspective on self-treatment of COPD exacerbations, 
focusing specifically on how patients decide for the right moment to start treatment 
with antibiotics and/or oral corticosteroids, what they consider important when 
making this decision and what aspects might interfere with successful implementation. 
 
 
 To explore GPs’ accounts of their decision-making about treatment with antibiotics 




3 Design, methods and procedures 
3.1 Theoretical and methodological considerations 
A principal part of designing a research project is to make explicit the ontological and 
epistemological assumptions of the researcher. Ontology refers to assumptions about the 
nature of reality. Epistemology makes assumptions on how it is possible to know something 
about reality, asking: “What is the relationship between the knower and what is known?”, 
“How can we know what we know?” and “What counts as knowledge?”99. In other words, 
these concepts relate to the researcher’s position regarding which social phenomena exist, 
how they are related, how they can be investigated, and how it is possible to know something 
about them100.  
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Medical science can be regarded as both a natural and humanistic science. In this sense, it 
may be situated within both a relativist and a realist tradition. Predominantly, I would situate 
my research in relativist tradition, which rejects the idea of one true reality but acknowledges 
multiple realities100. Yet, the main aspect for me is not to determine the existence of multiple, 
constructed realities, but how these influence social action and interaction. This is described 
in what Blaikie refers to as being a “Depth realist”. Accordingly, reality consist of natural and 
social structures, of which the latter depend on the social actors’ activities and their 
conception of their activities100. Such conceptions are influenced by social forces, such as 
politics and institutions, but also through direct interaction between persons101,102. Behaviour, 
or action, is contextually dependent, e.g. it depends on the meaning people pose on their 
experiences, objects, events and others’ behaviour. The symbolic interactionist perspective 
offers a socio-psychological approach to understanding human behaviour through emphasis 
on the “importance of symbols and interpretative processes that undergird interactions”103. 
Action, interaction and symbolic understanding are informing each other, and are dynamic in 
nature104. Moreover, referring to Blumer, Charmaz and Belgrave stress that “social interaction 
forms human conduct instead of being merely a means of expressing or releasing it”104. They 
note that, even though social structures and traditions exist, they rather shape than determine 
behaviour, which is why individuals’ reaction to social, contextual or historical structures can 
vary104. Symbolic interaction can therefore be regarded as a counter position to “behaviorism 
and mechanical stimulus-response psychology”103, and may therefore be a useful theoretical 
concept to get insight into how peoples’ understanding of their social world shape their 
actions. Through such an understanding, it may for instance be possible to gain knowledge on 
“what is most important to people, what will be most resistant to change, and what will be 
necessary to change” when institutional structures, programs or organizations develop103. 
Referring to Herbert Blumer, one of the founders of Symbolic interactionism, Patton notes 
that one way of getting insight into human behaviour that is based on interaction and 
interpretation, is to interview ‘experts’, i.e. key informants, who can “take the researcher into 
the phenomenon of interest”103.  
Further, Mishler’s concept of the two voices - the “voice of the lifeworld and voice of 
medicine”105 - gives a sense of what the humanistic and natural view on medicine means for 
clinical practice. He applied Habermas’s Theory of Communicative Action, according to 
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which there are two dialectic types of rationality underlying clinical practice, e.g. the “voice 
of the lifeworld” and the “voice of medicine”: 
 
“The voice of the lifeworld refers to the patient's contextually-grounded experiences of 
events and problems in her life. These are reports and descriptions of the world of 
everyday life expressed from the perspective of a “natural attitude”. The timing of 
events and their significance are dependent on the patient's biographical situation and 
position in the social world. In contrast, the voice of medicine reflects a technical 
interest and expresses a “scientific attitude”. The meaning of events is provided 
through abstract rules that serve to decontextualize events, to remove them from 
particular personal and social contexts.”105 
 
The relevant aspect here is that there can be fundamental differences in the principles 
on which medical ‘actions’, e.g. treatment decisions and help seeking decisions, are based. 
There can be different motivations for actions, and actions can be judged within varying 
frames of reference - it depends on the context, or the ‘worlds’, in which the phenomenon, in 
this case the “assessment and treatment of COPD exacerbations” takes place. Furthermore, I 
wish to mention Leder’s understanding of clinical medicine as interpretative activity106. He 
argues that 
“(…) clinical medicine can best be understood not as a purified science but as a 
hermeneutical enterprise: that is, as involved with the interpretation of texts. (…). (…) 
I suggest that the hermeneutics of medicine is rendered uniquely complex by its wide 
variety of textual forms. I discuss four in turn: the "experiential text" of illness as lived 
out by the patient; the "narrative text" constituted during history-taking; the "physical 
text" of the patient's body as objectively examined; the "instrumental text" constructed 
by diagnostic technologies. (…)”106 
 
According to this understanding, measurable outcomes such as prescribing and 
hospitalization rates are always the result of an interpretative activity from the patients’ and 
the physicians’ side, including interpretation of symptoms and their meanings, the physical 
examination and diagnostic tests. Both the “voice of medicine” and the “voice of the 
lifeworld” are represented here. In terms of patients’ decision-making for self-treatment and 
help seeking, one could say that behaviour in a situation of ill health is not simply a direct 
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reaction to physical symptoms resulting from a biological process, but rather results from 
interpretative processes through which persons give meaning to their experiences (e.g. of 
symptoms) and social encounters. GPs, who encounter a COPD patient with deteriorating 
symptoms, can only assess and evaluate symptoms and signs through interpretation of the 
patients’ history, of bodily signs and test results.  
This thesis aims to explore the management of COPD exacerbations in primary care, 
and sees both the “voice of medicine” and the “voice of the lifeworld” as relevant to clinical 
practice and health and illness behaviour. The “voice of medicine” may best be represented in 
for instance EBM standards or guidelines. The “voice of the lifeworld” may reside in the 
perspectives of those who indeed practice and behave on a daily basis, who act upon 
interpretations of experiences and social encounters, thereby creating the social phenomenon 
of ‘COPD care’. The main part of this thesis addresses aspects of ‘COPD care’ within a 
conceptual framework that emphasizes the primacy of social context, relations and 
interaction. To produce scientific knowledge of this, there are different approaches, or 
methodologies, and one may differentiate between quantitative and qualitative methods1. 
While quantitative methodology is traditionally grounded in a realist tradition, qualitative 
methodology is grounded in a relativist tradition. Both have their strengths and weaknesses. 
Simply put, while quantitative methods can be more suitable to answer questions on 
“numerical matter such as extent, distribution, or differences”, qualitative methods can be 
used to study, among other things, “human and social experiences”107. Choosing a method 
means also to make a choice regarding the type of knowledge that this method is able to 
produce. This thesis is primarily a qualitative research project using interviewing as method. 
Qualitative interviewing draws on conversations and language. Referring to Gadamer, Kvale 
and Brinkmann write that “we are conversational beings for whom language is reality”108. 
Knowledge about managing COPD exacerbations gained through interviewing is, from this 
perspective, useful to tell us something about the reality and the meaning-making processes of 
the social actors, e.g. COPD patients and GPs.  
 
3.2 Methods 
In this section, I will describe the methods used for the three studies, including the designs of 
the studies, preparations for data collection, data collection, data analysis and reporting of 
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findings. I will focus mainly on the ‘procedural’ aspects of the methods and on describing the 
steps undertaken during the research process. The discussion of the methods will be found in 
the ‘Discussion of methods’. 
 
3.2.1 Systematic review and assessment of guidelines 
Getting an overview over COPD guidelines and what is recommended regarding the 
management of COPD exacerbations was useful for two reasons. First, it served as a good 
starting point for learning critical assessment of scientific literature, including systematic 
identification of relevant literature for a specific research question, and comparison of 
scientific papers. Second, it would give me information about the ‘gold standard’ of managing 
COPD exacerbations, especially treatment criteria for antibiotics and oral corticosteroids. At 
this point, I thought such an overview could serve as a reference when investigating how 
treatment decisions were made by GPs and patients, respectively. 
In terms of method, I chose to orient this first part of my thesis on systematic reviews. 
Due to their methodological rigour, they compose the reference standard for synthesizing 
evidence109. The purpose of a systematic review is to identify single studies with results that 
can be synthesised after a critical appraisal to inform guideline development and clinical 
decision-making109. Ideally, systematic reviews should follow a pre-defined approach and 
protocol in order to provide methodological transparency and comparability. My aim was 
somewhat different from a ‘classical’ systematic review, as I aimed for reviewing guidelines 
instead of single studies, but found the steps provided in tools for conducting systematic 
reviews useful also in my case. I chose the PRISMA statement and check-list (Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis)110 and AGREE II tool 
(Appraisal of Guidelines for Research and Evaluation)111 to guide the development of my 
protocol on.  
The PRISMA statement is a guideline that recommends which items to include in a 
systematic review protocol, and provides an approach to the search strategy and eligibility 
assessment of the literature110. The AGREE tool is an instrument which “evaluates the 
process of practice guideline development and the quality”111.  
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The main aim of the search strategy should ensure that all documents published in English or 
Scandinavian language within the last ten years, containing recommendations for treating 
COPD exacerbations with antibiotics and/or oral corticosteroids would be identified. 
Therefore, we used the rather less specific search term “Chronic Obstructive Pulmonary 
Disease AND (Guideline OR Recommendation)”, accepting the relatively high number of 
matches in the first place. As the main interest was in the applicability of guidelines to a 
primary care population, I focused the appraisal of guideline development on transparency in 
reporting guideline development, stakeholder involvement and editorial independence. For 
the same reason, focus for appraising the underlying evidence was on study setting, study 
design and inclusion and exclusion criteria. Figure 1 shows the systematic database search 
and the eligibility assessment. After the search and eligibility assessment, I assessed the 19 
COPD guidelines according to the aims of the study, and organized the findings in tables.  
Furthermore, we extracted recommendations about patient assessment for treatment with 
systemic corticosteroids and antibiotics. If recommendations were given separately for 
inpatients and outpatients, only those for outpatients were considered (Guideline study112). 
The publication process was relatively ‘easy’, but it was interesting to me that particularly one 
reviewer was very critical to how I discussed the usefulness of spirometry in the assessment 
of COPD exacerbations. In the end, I had to moderate my, and my supervisor’s stance to 






Figure 1 Flowchart describing the systematic search and eligibility assessment (Guideline study112) 
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3.2.2 Interview studies 
The Patient study and the GP study were interview studies. Kvale and Brinkmann108 have 
described seven phases an interview design and study ideally consists of:  
 
1) Thematising: formulate the purpose of the study and conception of theme  
2) Designing: design study in regard to obtaining the intended knowledge and moral 
implications 
3) Interviewing: based on an interview guide, reflective approach about knowledge 
sought and interpersonal relation of interview situation 
4) Transcribing: preparing the material for analysis 
5) Analysing: decide upon the modes of analysis 
6) Verifying: ascertain validity, reliability and generalizability 
7) Reporting: report results according to scientific standards, considering ethical 
aspects of reporting  
As a novice researcher, I appreciated such a stepwise protocol. However, I did not strictly 
follow these phases as ‘steps’ for my two studies, particularly not in the GP study as the data 
was already collected by the PEXACO group. I experienced that conducting an interview 
study encompasses, as Kvale and Brinkmann state, “surprises, design changes, and 
reformulation of concepts and hypothesis”108, which may require a continuous adaption to 
new circumstances. In the following, I will use these seven ‘steps’ as a heuristic structure to 
describe, among other things, ‘surprises’ I encountered, the ‘design changes’ I had to make 
and the ‘reformulation of concepts’ I was choosing. Even though Kvale and Brinkmann’s 
phases are originally related to individual interviews, they are also relevant for a focus group 
design. Focus group interview, however, also encompass other important phases, such as 
sampling and composing the focus groups. Importantly, the sixth phase ‘Verifying’ will 
mainly be discussed in the ‘Discussion of methods’. 
 
3.2.2.1 Patient study using semi-structured interviews 
Thematising and designing 
Initially, the aim of this study was quite broad and explorative, i.e. to get an insight into how 
COPD patients self-manage worsening symptoms. This included, but did not require that the 
participants had received or used antibiotics and oral corticosteroids for self-treatment. The 
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first round of recruiting participants started on this basis. Since the overall interest was in 
investigating practice of routine care, we wanted to recruit via GPs, outpatient based 
pulmonologists or hospital based pulmonologist - whom we knew would occasionally instruct 
COPD patients in self-treatment. Recruiting via the pulmonology department of the 
University Hospital of North Norway (UNN) seemed attractive due to the ‘high 
concentration’ of COPD patients, yet we were concerned that the sample would be too narrow 
and specific in terms of disease severity, use of health care services and residential area. 
Moreover, the hospital’s will to collaborate did not seem great at that point. Recruiting via 
general practices would have been a feasible alternative, yet would probably be long-winded. 
There are certainly COPD patients on GPs’ patient lists, but it seemed difficult for the GPs to 
remember which patients had self-treatment medications. In the end, we recruited via the 
responsible physician at Skibotn Rehabilitation Centre, a heart and lung rehabilitation 
institution in North Norway. Recruitment was done by sending out invitation letters including 
consent forms to 74 COPD patients who had participated in the rehabilitation program in 
2012/2013, and asked to return written consent and a note about age, occupation, civil status 
and whether they had received medications for self-treatment of worsening symptoms. I 
considered that the advantages with this sampling strategy, i.e. high geographical variation in 
residence, age, occupation and level of care where they had received self-treatment plans 
from, would outweigh the disadvantages, i.e. that all had gone through a lung rehabilitation 
program. We assumed that there would be a certain homogeneity regarding education about 
COPD and COPD management the potential participants would have received.  
The recruitment process was smooth to begin with and there was a great willingness to 
participate. We received (in total) 45 consent forms and one email with written consent. In 
this first round of recruiting, we contacted 15 respondents, chosen purposefully to include 
COPD patients from rural and urban areas, both sexes and with different working and civil 
status, and made appointments for the interviews. I ended up with 15 participants, of which 8 
had received, and 7 had not received self-treatment medications (see Table 1). Yet, during the 
interviewing phase, I needed to reconsider my strategy (see Figure 2 for the whole 





Figure 2 Flowchart showing the recruitment and sampling process (Patient study113) 
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Interviewing and transcribing 
Semi-structured interviews are usually conducted based on an interview guide, which is a 
collection of question or main themes the researcher wants to cover during the interview108. It 
is not necessary to strictly follow these questions, but the guide can help the researcher to 
keep track of his agenda. We developed the interview guide (see Appendix) based on earlier 
research in the field, focusing on recognition of COPD exacerbations, experiences with and 
reasons for using antibiotics and/or oral corticosteroids, attitudes towards being a ‘self-
treating’ person and experiences and perspectives on seeking help from health professionals 
when experiencing worsening COPD symptoms. The formulation of the questions required a 
careful consideration about the use of terms. For instance, we chose not to use the term 
‘COPD exacerbation’, as we did not know what the participants would associate with this 
term. In order to find out about exactly this, one of the first questions was whether they knew 
the term ‘KOLS forverring’ (which is like ‘COPD worsening’) and what this meant for them. 
 
In autumn 2014, I travelled through Northern Norway to conduct the interviews – at 
least the first eight ones. All eight participants, except two who preferred to meet me at UiT 
The Arctic University of Norway, agreed on being interviewed in their homes. Interviewing 
the participants in their homes had several advantages. Obviously, it was easier for me to 
travel than it was for the participants. More importantly, however, being able to see where and 
how the participants lived would provide contextual background information for adapting the 
interview guide to the individual and for data interpretation. 
 
During the first interviews, I recognized that I had been quite naïve in terms of 
assuming that having self-treatment medications available automatically meant to use them. 
Moreover, it seemed as if there were quite big variations regarding the way and the purpose 
the participants had received antibiotics and/or oral corticosteroids for, and regarding the self-
treatment instructions they had been given. For many participants, self-treatment was a 
supplement and not an alternative to contacting a doctor. Moreover, I realized that recruiting 
both patients who had and who had not received self-treatment medication could be 
problematic, as I would end up with self-treatment stories that would on the one hand be 
based on real experiences with self-treatment and on the other hand on hypothetical self-
treatment scenarios. I considered this a disadvantageous mixture of theoretical and 
experiential knowledge. Therefore, after thorough reflection, we narrowed down the study 
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aim to now focusing on self-treatment with antibiotics and oral corticosteroids and on help 
seeking. Subsequently, we started a second round with invitation letters to include more 
participants who had actually received self-treatment medications (see Figure 2). I used the 
same interview guide (see Appendix), but left out certain questions that did not correspond to 
the changed study aim. In this second round, I included four more COPD patients with self-
treatment plans and finally ended up with 19 interviews (see Table 1). 
In retrospective, I would say that we could have avoided this ‘detour’ - and the critical 
questions by reviewers on the matter in the publishing phase - by more thorough reflection 
























Table 1 Participant demographics (Patient study113) 
Participant Sex Age Civil status Working status Residence FEV1/FVC 
1* m 60 married partly disabled urban 32% 
2* m 73 married retired rural 98% 
3* f 77 widow disabled rural 34% 
4* f 70 married housewife rural 39% 
5* m 64 partner disabled urban 37% 
6* m 65 married disabled urban 45% 
7* f 62 divorced disabled rural 59% 
8* m 65 single employed urban 63% 
9 m 64 married disabled rural n.a. 
10 m 72 married retired urban 47% 
11 f 65 divorced  disabled rural 39% 
12 f 75 married retired urban 91% 
13 f 55 single disabled rural 84% 
14 m 58 single disabled rural n.a. 
15 m 65 married self-employed urban 45% 
16* f 74 married housewife urban n.a. 
17* m 64 partner disabled urban 20% 
18* m 71 widow retired rural 22% 
19* m 60 single disabled urban 64% 
m=male, f=female; FEV1/FVC=forced expiratory volume in one second/forced vital capacity;              
n.a. = not available                                                                                                                                                                              
* participants who have received antibiotics and/or oral corticosteroids for AECOPD self-treatment 
and whose interviews were coded in detail. 
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Analysing, verifying and reporting                                                                                                  
I used thematic analysis as described by Braun and Clarke114 for both the Patient study and 
the GP study. In this section, I will give an introduction to this analysis method and how I 
applied it in the Patient study (below, I will describe relevant aspects of analysing the FGDs).  
Thematic analysis has a less strong tradition in qualitative research than for example 
Grounded Theory, yet it is popular and widely used within health disciplines115 (B&C 2014). 
It is regarded as a “comparatively easy to learn qualitative analytic approach, without deep 
theoretical commitments” and it is considered that “it works well for research teams where 
some are more and some are less qualitatively experienced”115. Therefore, thematic analysis 
appeared as an attractive method to use in my case, and I followed the recommendation of my 
supervisor Mette Bech Risør to choose this method. Braun and Clarke described thematic 
analysis as a “robust, systematic framework for coding qualitative data, and for then using 
that coding to identify patterns across the dataset in relation to the research question”115, yet 
emphasize its variability and flexibility in terms of analytic depths and theoretical 
frameworks. Flexibility requires the researcher to make choices including the epistemological 
stance (e.g. realist or constructionist thematic analysis), the type of analysis (broad description 
of the dataset or detailed account of one or more particular aspects), how to identify patterns 
(inductive or deductive analysis) and the types of themes (semantic or latent themes)114. For 
this study, my particular interest was in the patients’ perspective on self-treatment of COPD 
exacerbations. Therefore, I applied an initial inductive approach to data analysis – i.e. that 
theme development was steered by the data and not by a pre-determined theoretical interest or 
coding framework114. My analysis aimed at developing semantic themes, based directly on 
what was said, on the surface of meanings. Thematic analysis as described by Braun and 







Table 2 Phases of thematic analysis as described by Braun and Clarke114 
Phase Description of process 
1. Familiarizing yourself  
     with the data 
Transcribing data (if necessary), reading and 
reading the data, noting down initial ideas 
2. Generating initial codes Coding interesting features of the data in a 
systematic fashion across the entire data set, 
collating data relevant to each code 
3. Searching for themes Collating codes into potential themes, gathering all 
data relevant to each potential theme 
4. Reviewing themes Checking if the themes work in relation to the 
coded extracts (Level 1) and the entire data set 
(Level 2), generating a thematic ‘map’ of the 
analysis 
5. Defining and naming themes Ongoing analysis to refine the specifics of each 
theme, and the overall story the analysis tells; 
generating clear definitions and names for each 
theme 
6. Producing the report The final opportunity for analysis: Selection of vivid, 
compelling extract examples, final analysis of 
selected extracts, relating back of the analysis to 
the research question and literature, producing a 
scholarly report of the analysis 
 
Similar to Braun and Clarke’s description of data analysis as a “recursive” rather than 
“linear” process114, I experienced that all phases were overlapping and that it was necessary to 
move back and forth between the phases to find a balance between keeping closeness to the 
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data and reflective distance. Such ‘moving’ between phases means also to move between the 
data set, the analytic categories, and literature. Writing and visualization of my thoughts, as 
well as periods with literature readings were very important for me to keep track of my ideas, 
potential themes and choices. The Figures 3 and 4 give an example of how I visualized my 
thoughts during the analysis process.  
 
  





Figure 4 Visualization of ideas and potential themes in the analytic process (Patient study113) 
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Having a reflexive relationship to the data, going back and forth between analytic 
categories and the data, and contextualizing the data is important to verifying that the reported 
results express the participants’ concerns and a way of ensuring the trustworthiness of the 
results116. To achieve this, I used mind maps to create a visible link between the data and 
potential analytic themes, discussed codes and categories with my supervisors and peers with 
other personal and professional backgrounds, and engaged with existing literature in the field 
as well as theoretical concepts (see Discussion of methods). Overall, taking the step from 
initial coding to the final themes required a lot of curiosity, creativity and patience to let ideas 
emerge, and to develop them during reading, thinking and discussions. Using existing theory 
or theoretical concepts is also a form of validation117. Particularly theoretical concepts from 
sociology and psychology, e.g. the health belief model118, the Common Sense Model of 
Illness Representation82, Attachment Theory119 and the Necessity-Concerns-Framework120, 
which I finally use in the Patient study, appeared relevant and suitable to use in my analytic 
work. Using theoretical concepts as a tin opener117 to ‘open up’ my findings was indeed ‘eye-
opening’. I experienced the writing up of my results and discussing them in the light of 
existing literature and theory as part of the analytic process rather than separated from the 
analysis. Overall, reporting is a sum of the leads made in the design process, and writing a 
condensation of presumptions concerning data. The researcher needs to ask how to convey the 
content of the data and how to align it with the media it is possible and relevant to publish in. 
First of all, however, I had to choose the journal I wanted to publish the results in. I chose a 
journal with a rather broad scope (BMC Family Practice) that addresses a large audience, 
since I regarded my findings both interesting for the COPD management debate, but 
particularly the self-management and help seeking aspects very relevant to other primary care 
contexts. I experienced the process of article writing, and the feedback from supervisors, 
editors and reviewers during the writing and publishing process as helpful to further refine 
themes and bring even more forward the ‘essence’ of meanings in the data.  
 
3.2.2.2 GP study using focus group discussions 
Thematising and designing 
In contrary to the Patient study, the data for the GP study was already collected as part of the 
PEXACO project when I engaged in the research project. Therefore, I had to approach 





“- How do European GPs and pulmonologists think exacerbations of asthma and COPD in 
adults should be assessed and treated, and in particular what role do the Anthonisen criteria 
play in the decision on antibiotic treatment?”  
 
The data I was to use was based on 21 FGDs discussions (7 countries, 3 FDGs per 
country). It was collected to cover several research projects and studies within the overall 
PEXACO project, aiming for instance to understand overall concerns of GPs and 
pulmonologists about primary care management of COPD exacerbations98, or to explore these 
healthcare professionals’ perspectives on self-treatment71. From my time as a research 
assistant, during which I translated the Norwegian FGDs into English, I had already an idea 
about the content of the (at least Norwegian) FGDs. As my main interest for the GP study was 
in the GPs' perspective, I chose to include only the FGDs with GPs - contrary to the study of 
Risør et al.98. Another reason was that the results of their study indicated that there are 
differences in how GPs and pulmonologists approach decision-making. Moreover, one can 
argue that GPs typically deal with less severely ill patients than pulmonologists, and treatment 
with antibiotics and/or oral corticosteroids may often be less necessary for COPD patients in 
primary care22,23, which is why we considered it important to explore the GPs’ perspective in 
particular. I further developed the original research question (see above) and the analytic 
approach. Early considerations for the research question included ‘gatekeeping’ and 
‘collaboration’ (with specialists) and ‘role of diagnostic tests and clinical examination’. 
Overall, I experienced this as a rather challenging process, as I felt that having the data 
already complete limited the spectrum of research questions that were adequate according to 
the nature of the data, i.e. cross-cultural FGDs. I tried to get as much information as possible 
about the thoughts and ideas from early phases of the project I was not involved in, as I felt 
that being able to follow the others’ strings of thought eased my further decisions, and helped 
me to distinguish my research question from the analysis of Risør et al.98. I had many 
discussions at different occasions about the analytic focus for FGDs, and went back and forth 
reading the data and relevant literature. Moreover, I thought quite a lot about the cross-
cultural dimension of the data. A teacher in a focus group course once pointed out that there 
was a considerable risk that my interpretations of the GPs’ stories would be “influenced by 
prejudices rather than systematic knowledge about the preconditions of healthcare systems 
and cultures”. Other peers I discussed this with were not that worried about the healthcare 
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systems differences, as long as I was careful and reflective in my interpretations. Keeping 
these thoughts and the impressions from first readings in mind, I finally decided to focus on 
aspects of decision-making concerning treatment with antibiotics and oral corticosteroids and 
hospitalization, and what GPs consider relevant when deciding upon managing COPD 
patients with deteriorating symptoms.  
 
Sampling, interviewing and transcribing                                                                                         
The FGDs had been conducted in 2011, and where transcribed as well as translated into 
English before I started my PhD project. The PEXACO researchers designed a study of 21 
(3x7) FGDs. Six of the seven participating countries (Netherlands, Poland, Russia, Germany, 
Wales and Norway) were selected from earlier research collaboration networks (General 
Practice Research on Infections Network (GRIN) and Genomics to combat Resistance against 
Antibiotics in Community-acquired LRTI in Europe (GRACE)). Hong Kong joined later - 
originally meant to serve comparative purposes to the European countries. There were three 
rounds of FGDs in each country with new participants each time, i.e. FGD1 with GPs only, 
FGD2 with pulmonologists, and FGD3 with both GPs and pulmonologists. In order to align 
the data collection method in each country, all researchers involved in the data collection 
joined a three-day workshop including instructions on the FGD method, qualitative research 
and an exercise. Participants for FGD1, the sample for my study, were sampled purposefully 
through personal contacts and professional networks. The sample covered GPs from both 
urban and rural practices and included GPs with both long and short experience in general 










Table 3 Overview over recruitment process and participants (GP study121) 













at a meeting 
12 7 7 group practices 
only 
rural  







at a meeting, 
personal contacts 
59 27 6 group practices 
only 
both urban 
and rural  
Wales postal invitation 
letter send in two 
rounds and 
followed up with 
telephone calls 
















Hong Kong email invitations, 
announcement 
at meetings 




Before conducting FGD1, the first topic guide was developed by Mette Bech Risør and 
Hasse Melbye with input from collaborating countries. A pilot interview was conducted in 
Tromsø in order to adjust for formulations, phrases and questions. The development of the 
interview guides for FGD2 and FGD3 is described comprehensively in Risør et al.’s article98. 
The final interview guide for FGD1 contained the following topics:  
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- assessment and medication, hospitalization, self-treatment, use of guidelines, 
challenging or difficult situations, most important problem, and improvement of 
clinical practice. 
 
Even though I was involved in translating the Norwegian FGDs into English, and had 
therefore an idea about what they were about, I did not feel as 'close' to this dataset as to the 
semi-structured interviews I conducted myself for the Patient study. Moreover, by translating, 
the transcripts had already gone through a process of interpretation. Some sentences and 
passages in the translated transcripts were hard to make sense of because of the translations' 
quality. I tried to resolve unclear passages mostly by asking the researchers in the respective 
countries, or discussing them with my supervisors. Overall, I believe I managed to account for 
these obstacles and not let them negatively influence the data analysis and the validity of my 
results (see Discussion of methods). 
 
Analysing, verifying and reporting 
I also used thematic analysis for the analysis of the FGDs, and will not repeat the general 
aspects on this method. My initial aim for analysis was to explore the decision-making 
process in terms of cognitive processes, yet realized very early (and was in fact warned that 
this would be very difficult) while reading the interviews in the first analytic phase, that this 
was impossible given the nature of the data. That is, the data contained GPs’ narratives that 
are based on their own reflections about decisions they made in the past, and can therefore not 
give insight into cognitive processes that occur during an actual decision-making. In the end, 
my actual aim was much more convenient: what the data could offer was knowledge about 
what GPs consider important to their management decisions. Table 4 gives some examples of 









Table 4 Examples of the interpretation and abstraction process from data to final themes (GP        
study121) 




“I think it’s difficult 
because a lot of these 
patients do have chronic, 
their sputum is chronically 
um there is all sorts of 
bacteria it is difficult to be 
guided by things such as 
sputum culture because 
it’s often going to come 
back as positive whether 
or not it’s acute …. “ 
 








decisions account for 
medical uncertainty 
“It’s different patients, 
there are some patients 
that play there symptoms 
up and others that play 
them down but I mean if 
you went initially on 
symptoms you would be 
giving them antibiotics 
every month so when they 
perhaps don’t need it.” 
Cannot rely on the 
validity of 
information 
Knowing the patient 
as a person 
Interpreting 
information relevant 
to the person 
Knowing the 
patient 
Knowing the patient 
“If she is a worried lady 
and self wants to be in a 
hospital I would set the 
threshold even lower I 
suppose.” 
Patient makes final 
decision about 
hospitalization 





try…we don’t write: “for 
hospitalization”, but only 
“for diagnostic evaluation 
in the Admission Room”. 
Sometimes they ‘buy’ such 
things…! 













   
As mentioned earlier, the FGDs covered more topics than were relevant for my study, which 
is why I did not code the whole FGD material and skipped certain passages when the topics 
were clearly not relevant for my research questions (such as discussions about self-treatment 
and smoking). However, I found the data could be too broad and too superficial at times. 
Semi-structured interviews might have provided more in-depths insight into the 
phenomenon1. Compared to the Patient study, where I was involved from the beginning, 
having a readily collected and transcribed dataset available made the conduction of the GP 
study less time consuming. The analysis of the FGDs differed in several ways from analysing 
the semi-structured patient interviews. For instance, the dynamic nature of FGDs made the 
context in which something was said more important to the interpretation. Analysing the 
FGDs from different countries, was, compared to the patient interviews, more challenging 
since I was not very much familiar with the healthcare systems in the countries other than 
Norway and Germany. Yet, since I had collected information about the other healthcare 
systems of the other five countries during my time as a research assistant, I knew about the 
overall organization of the systems. The translated interviews were in some cases difficult to 
understand, and it could be necessary to ask the researcher of the respective country about the 
meaning of a certain term or the context of a participant’s narration. This ongoing dialogue 
within the research network was a useful way to verify my own understanding of these 
passages. As in the Patient study, I used mind maps and drawings to visualize my data and 
preliminary themes, and shared codes and further development to themes with my supervisors 
and other peers. We could resolve disagreements about the meaning of data units through 
discussions and further reading of literature and theory. For the GP study, I read particularly 
about medical uncertainty, different theoretical approaches to decision-making (such as ‘gut 
feelings’122 and ‘mindlines’123 and about patient-involvement124. Theory and literature served, 
as in the Patient study, as tin opener to data interpretation. In the end, I organized my results 
in four final themes that we reported in a scientific article. For the GP study, I choose a 
journal with a scope on COPD research (The International Journal of COPD), primarily 
because I considered my findings most relevant in the context of ongoing discussions on 
managing COPD exacerbations, but also because this journal had a good reputation in terms 
of an easy and fast review process. For more reflection and discussion of methods and use of 
the methods, see the ‘Discussion of methods’. 
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3.3 Ethical formalities 
I followed general ethical principles as described by The Norwegian National Committees for 
Research Ethics125 and the Helsinki Declaration126, which draw on respect, good 
consequences, fairness and integrity. However, all rules and guidelines have to be understood 
contextually and applied according to the nature of the research project, and should be 
reflected on continuously108 (see also ‘Discussion of methods’).                                                                                                                        
Formal requirements were met in the same way in both the Patient study and the GP 
study. They were presented to the Regional Ethical Committee, which found that their 
purposes did not belong under their jurisdiction according to the Norwegian Health Research 
Act. Therefore, both studies were exempted from their approval. The studies were reported to 
the Norwegian Social Science Data Services, including changes that were made during the 
Patient study. Written informed consent on participation was obtained from all the 
participants in both studies. Letters to potential participants were sent out with general 
information about the study and a consent form. The persons who returned a signed consent 
form were contacted by me (Patient study113), or the researcher responsible for data collection 
in the respective country (GP study121). For the Patient study, I informed the potential 
participants orally about the details for the interviews and the possibility to quit the study at 
any point. I contacted also those who we chose to not include in the first place, thanked them 
for their interest and explained why they could not be included at this point. I obtained oral 
consent from all participants to contact them again if necessary. All participants were 
informed orally that their stories would comprise the raw data for this study and gave oral 
consent to outsourcing of the interviews’ transcription, to publication of the analysed data and 
citations after removal of personal information. The participants received a gift coupon of 500 
Norwegian crowns as compensation for their participation. Confidentiality was ensured by 
secure separate storage of documents containing information that could identify the 
participants for both studies. The person hired to transcribe the patient interviews was 
carefully informed regarding confidentiality and signed a special contract on discretion.                                                          
For the GP study, the participants were informed about how the researchers would proceed 
with the data, e.g. transcription, analysis and article writing. The transcription of the 
anonymized data and translation into English was conducted by the moderators, the project 
leaders or a language assistant in the respective countries. Also the participants of the FGDs 
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received a financial compensation for their participation according to national standards for 
compensating physicians.  
 
4 Results 
This thesis on the management of COPD exacerbations in primary care regarding treatment 
with antibiotics, oral corticosteroids and hospitalization resulted in three studies with the 
following titles: 
1. “When should acute exacerbations of COPD be treated with systemic corticosteroids and 
antibiotics in primary care: a systematic review of current COPD guidelines” (Guideline 
study)112 
2. “Self-treatment of acute exacerbations of chronic obstructive pulmonary disease requires 
more than symptom recognition – A qualitative study of COPD patients’ perspectives on self-
treatment” (Patient study113 - currently under review) 
3. “How do general practitioners implement decision-making regarding COPD patients with 
exacerbations? An international focus group study” (GP study121) 
 
Here follows the summary of the results 
Guideline study                                                                                                                               
The results showed that treatment recommendations were mostly symptom-based. For oral 
corticosteroids, criteria were often recommended universally for all patients with an 
exacerbation, with patients with (severe) dyspnoea or all patients with an underlying moderate 
to severe COPD. For antibiotics, recommended criteria were mostly based on the Anthonisen 
criteria from 198725 (increased dyspnoea, increased amount of sputum, and increased 
purulence of sputum), with emphasis on sputum purulence. The use of diagnostic tests was 
only recommended in a few guidelines. The patients in the trials on which the 
recommendations were based were a rather selected group of COPD patients, i.e. that most 
trials were conducted with hospitalised patients, that the exclusion rates before randomisation 
were high in many trials, and that the patients were often characterised by severely reduced 
lung function and low prevalence of cardiovascular comorbidities or diabetes. Owing to the 
small number of GPs in the guideline development committees, we found that there was an 
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imbalance between the expertise distribution in guideline development and the percentage of 
care that is actually provided in primary care. Overall, there was a considerable lack of 
transparency, as the literature review was often not documented comprehensively. A number 
of guidelines were financed by pharmaceutical companies, or did not report their funding 
sources.  
 
Patient study                                                                                                                                   
The findings showed that, overall, the participants considered the opportunity for self-
treatment as a practical alternative to help seeking, and that having medications on standby 
gave an extra feeling of safety. Many participants did not remember when or with what 
instructions they got the standby medications for the first time, and most of them would not 
talk about these medications with their doctors. When experiencing worsening symptoms, the 
participants used their experiential and lay-medical knowledge to weigh up risks and benefits 
of the illness and the medications side effects before starting treatment or seeking help. 
Concerns about the medications’ potential side effects emerged as highly relevant to their 
assessment on whether to start treatment or to ‘wait-and-see’. Some participants would 
principally contact a healthcare professional before starting treatment. Having regular 
exacerbations with repeating symptom patterns and positive experiences with treatment 
seemed important to their feeling of confidence in self-treatment. Yet, also these participants 
could have difficulties with interpreting symptoms in terms of finding the right time to start 
treatment, especially those who had strong concerns regarding side effects. Another problem 
reported by some participants was treatment failure. In both cases, they could appreciate 
assistance by a health care professional, but seeking help, however, was not natural to all 
participants. Some, even though appearing confident enough to deciding alone, consulted a 
healthcare professional as a rule before starting treatment. Others, mostly those who also 
reported negative experiences with having received help previously, would stick to self-
treatment as long as possible in order to avoid unpleasant or ‘useless’ consultations with 
doctors. Another pattern of help seeking was characterized by a desire for assistance but, at 
the same time, insecurity regarding the legitimacy of seeking help, as participants could feel 




GP study                                                                                                                                          
The results showed that the GPs’ wish to make medically appropriate decisions could be 
challenged by medical uncertainty and worries regarding potentially severe outcomes if 
having left a serious condition untreated. Knowledge about the patients, a holistic 
understanding of illness and the patients’ own experiential knowledge emerged as a valuable 
supplemental framework for GPs to interpret the often diffuse clinical picture, and to make 
reasonable decisions under medical uncertainty. Moreover, we found that decisions were not 
merely the GPs’ ‘brain-child’, but would rather emerge from a process of interpretation, 
communication and negotiation between the involved actors, including patients, patients’ 
peers and healthcare professionals. Moreover, GPs’ decisions were shaped by opportunities 
and limitations resulting from the healthcare system’s organizational structure and cultural 
code of conduct.  
 
5 Discussion 
5.1 General discussion 
This thesis aimed to explore the management of COPD exacerbations in primary care, 
focusing on treatment with antibiotics and/or oral corticosteroids, help seeking and 
hospitalization. We have conducted three studies using different methodologies and methods, 
all of which illuminate different parts of the overall phenomenon. The results of each study 
are discussed in the three articles112,113,121. For this general discussion, I will try to integrate 
the different perspectives to draw a comprehensive picture of how COPD exacerbations are 
managed in primary care, and to highlight aspects that I consider overall relevant to improve 
current and future care of COPD exacerbations.  
 
5.1.1 A multidimensional framework for interpreting worsening symptoms 
One common aim of all the three studies was to get insight into which criteria should be 
applied when deciding about treatment with antibiotics and oral corticosteroids in primary 
care (Guideline study112), and what is relevant to making these treatment decisions in ‘real 
life’ (GP study121 and Patient study113), respectively. The treatment criteria in COPD 
guidelines were mainly symptom-based. For antibiotics, criteria were comparable to the 
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Anthonisen criteria (increased sputum purulence and volume and increased dyspnoea)25, yet 
with more weight on sputum purulence. The criteria for oral corticosteroids rested largely on 
the severity of dyspnoea but were otherwise often recommended universally for all patients 
with exacerbations. In the Guideline study, we argued that these recommendations are 
probably of little help to target treatment for COPD exacerbations, as for instance 
cardiovascular comorbidities can present with similar symptoms12,127. Moreover, we 
concluded that the applicability of the recommendations to a primary care setting is probably 
low (Guideline study112). In primary care, patients have typically less severe underlying 
COPD, but more comorbidities than the patients in the trials the recommendations are based 
on128. The findings from the GP study and the Patient study support the limited usefulness of 
symptom-based criteria to making treatment decisions. One of the main findings from both 
studies was that basing treatment decisions on clinical criteria may be difficult due to slowly 
developing, diffuse symptoms that do not clearly indicate the need for treatment. Both 
patients and GPs seemed aware of the challenges related to comorbidity and the potentially 
multiple underlying causes of symptoms.  
 
Clinical examination, diagnostic tests and biomarkers played a minor role or no role in 
the assessed COPD guidelines (Guideline study112). According to the GPs in the GP study, 
many seemed to routinely conduct a clinical examination, and could consider findings, for 
instance wheezing or a combination of different clinical signs, as relevant to their decision- 
making. Pulse oximetry, specifically a drop in oxygen saturation, seemed ‘popular’ among the 
GPs to assess overall disease severity, at least among GPs who had access to this test (GP 
study121). Only the Swedish guidelines recommended pulse oximetry for patient 
assessment/treatment (Guideline study112). In terms of biomarkers, CRP was only 
recommended in the Norwegian guidelines28, even though it is presented as a promising 
biomarker to target antibiotic treatment26,27. According to the GPs in the GP study, CRP could 
be very useful if significantly high or low, yet they stressed that this may not very often be the 
case in COPD patients. This finding mirrors that acute bacterial infections play a minor role 
in COPD exacerbations16. Diagnostic markers for viral infections or systemic inflammation 
may be more useful, yet such markers seem far from becoming a realistic diagnostic 




Overall, it seems as if a clinical examination, diagnostic tests such as pulse oximetry, 
and also biomarkers can assist the otherwise symptom-based assessment when findings are 
deemed significant. The perceived relevance of clinical/medical information from the 
assessment varied across countries. It seemed as if the GPs from Poland and Russia were, at 
least in the beginning of the discussions, more concerned with the clinical/biomedical 
assessment compared to the GPs from, for instance the Netherlands, who were to a larger 
extent stressing the importance of the social and psychological aspects from the start. 
Differences between European countries regarding disease-centeredness/patient-centeredness 
have been previously reported129. The GP study showed also that there were variations among 
the GPs to which extent they considered patient contact important for assessment. Some GPs 
insisted that ‘seeing’ the patient was important to their assessment, others seemed positive to 
prescribing treatment over the phone if the patients’ story was ‘convincing’ that treatment was 
necessary. These variations in patient assessment are mirrored in a study of Melbye et al., 
showing that only 59% of patients with severe COPD and asthma underwent a clinical 
examination before hospitalization (many were hospitalized after telephone contact)130. Both 
these and our findings suggest that, given the lack of overall useful clinical criteria and 
diagnostic tests, GPs apply different assessment strategies to patient assessment and decision-
making. Indeed, GPs certainly deal with medical uncertainty in a variety of ways131.  
 
The Guideline study suggested that following the recommended treatment criteria for 
antibiotics and oral corticosteroids is likely to result in treatment for the majority of COPD 
patients with worsening symptoms, even though this may not be medically appropriate 
(Guideline study112). I found that such rather categorical approach to treatment, i.e. for all 
COPD patients with exacerbations, was also present in the GPs’ narrations in the GP study. 
Yet, the GPs’ reasoning showed that their categorical treatment was not due to following 
guidelines but as a strategy to deal with medical uncertainty (GP study121). In the GP study, 
being ‘categorical’ with treatment was rather the result of a ‘better safe than sorry’ approach 
to managing ‘high risk’ COPD patients (GP study121). We argued in the GP study that the 
underlying problem leading to this categorical/precautionary decision-making could be an 
attempt to apply a biomedical interpretative framework to a clinical picture that is difficult to 
make sense of with biomedical knowledge, often lacking an identifiable biomedical cause 
(GP study121). As a possible solution, the GPs described another strategy that seemed to 
enable them to make more tailored management decisions for the individual patient. This 
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approach was based on an extended interpretative framework and application of different 
types of knowledge to make sense of the often diffuse clinical picture (GP study121). One 
main finding from the GP study was that the GPs’ clinical and personal knowledge about 
patients, including medical history, social circumstances but also “behaviour and 
cognition”132, was a valuable supplement to medical knowledge. Such knowledge seemed, for 
instance, to enable GPs to add a time perspective to patient assessment, i.e. evaluate symptom 
changes and to evaluate the role of social and psychological aspects to a patient’s illness. The 
latter is, in my view, particularly important given that anxiety and depression are common 
comorbidities in COPD patients8, and since anxiety may aggravate the experience of 
dyspnoea133. A continuous, long term relationship to patients, which is one of the 
cornerstones of primary care134, may be the key to GPs’ knowing their patients. 
Unfortunately, not all GPs have such knowledge about their patients135. However, as we 
argued in the GP study, with more awareness about the importance of contextual aspects to 
patient care, GPs may to a larger extent be able to recognize “contextual red flags”136 during 
the patient consultation.  
 
In addition to GPs’ knowledge about their patients, also the patients’ own experiential 
knowledge emerged as a valuable resource to making treatment decisions. The GPs seemed to 
consider the patients’ own opinion about the need for treatment as helpful, especially when 
feeling uncertain themselves (GP study121). Given the little usefulness of clinical criteria for 
making treatment decisions, the patients’ experience may indeed be a valuable resource. The 
reliability of diagnosis based on patients’ reporting has actually been validated137 and from 
the Patient study, we know that patients can in fact have considerable experiential knowledge 
from previous exacerbations to recognize symptom changes (Patient study113). The 
participants seemed able to judge whether symptom deterioration was related to, for instance, 
external circumstances (weather changes, smoke from candles) or whether ‘something was 
really going on’. In line with Willams’s study94, we found that experiential knowledge can 
have many faces, e.g. being an embodied feeling or consisting of more ‘visible’ clinical 
criteria such as coloured sputum or fever. Overall, the patients’ experiential knowledge 
seemed most valuable - both for self-treatment and for the GPs’ assessment - for patients with 
recurrent exacerbations that present with similar symptom-patterns and who have previously 
perceived an effect of treatment. Indeed, the Patient study and other qualitative studies79,138 
suggest that, even though the clinical presentation of COPD exacerbations can vary 
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considerably between patients, there seems to be a group of patients whose exacerbations are 
more or less predictable in their symptom presentation. This ‘subgroup’ of patients, which 
may fall under the “frequent exacerbator phenotype” of COPD139, may be most eligible to 
become confident ‘self-treaters’.  Interestingly, the development of this phenotype was based 
on patients’ experiences, e.g. on clinical records or patient recall, and not on biomedical 
research/aetiological/pathophysiological classifications in the first place139.  
 
Overall, our findings suggest that the patients’ expertise and other types of knowledge 
that are grounded in experience and relations is a valuable epistemological extension to the 
biomedical understanding of symptoms. A combination of and flexible use of different 
knowledge types and knowledge sources may be particularly relevant for the management of 
complex conditions such as COPD exacerbations, which are both acute and chronic in nature, 
and heterogeneous in terms of aetiology, pathophysiology, symptom presentation and 
severity.  The question arises how to integrate the different types of knowledge in for instance 
clinical practice guidelines and treatment recommendations, which, to date, primarily rest on 
the expertise of pulmonologists and other specialists (Guideline study112). It would be 
particularly interesting for a primary care setting to get more insight into if, and how, 
biomedical/aetiological and pathophysiological patterns correlate with the patients’ 
experience of symptoms and/or with findings from a clinical examination. Such knowledge 
could be useful to better predict the effect of antibiotics and oral corticosteroids without the 
use of advanced diagnostic technology and could inform both guidelines for primary care 
physicians and the development of individually tailored self-treatment plans. 
 
5.1.2 Perceptions of risk 
As described in the above section, slowly developing and diffuse symptoms as well as 
comorbidity can challenge ‘medically appropriate’ treatment decisions for both GPs and 
patients. However, one could argue that medical uncertainty is a common phenomenon in 
general practice, and just the fact that decisions are difficult may not fully explain for instance 
high hospitalization rates and apparent high use of antibiotics and oral corticosteroids. Indeed, 
the findings from the patient and the GP study uncover, in my view, that it is not the 
experience of uncertainty itself, i.e. the ‘lack of information’, but the worries/concerns about 
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possible severe consequences of ‘wrong’ decisions that are the biggest problem (Patient study 
113and GP study121).  
 
In the GP study, we applied a psychological explanatory framework that understands 
“action rather than inaction”140 as strategy to deal with uncertainty through avoiding 
unpleasant feeling and pondering after the decision is made141,142. Overall, we know from 
several qualitative studies on GPs’ work that their treatment decisions are, among other 
things, influenced by a desire to “minimize risk”143,144, and a feeling that they have to “protect 
their backs”145. In terms of hospitalization, our findings support other studies on GPs’ referral 
decisions in general. These studies show that referrals often have a re-assuring purpose for 
both the patient and the GP, and not a purely medical purpose146-151. However, the GPs’ 
stories revealed that they perceive COPD patients - as opposed to other, younger and 
‘healthier’ patients - as particularly vulnerable. It seems that this was a special risk attribution 
that lowered the threshold for ‘action’ considerably (GP study121). Certain symptoms, such as 
coloured sputum, may not have triggered antibiotic prescribing in a patient without 
underlying COPD. Indeed, an observational study on variations of GPs’ antibiotic prescribing 
for acute rhinopharyingitis suggests that it is mainly the patients’ characteristics - as opposed 
to a physicians’ practice style - that explains the choice of treatment. The authors found, for 
instance, that GPs were more likely to prescribe antibiotics ‘unnecessarily’ to patients with 
respiratory comorbidities152. This emphasizes, in my view, that, in addition to the perceived 
complexity of the illness and the ‘difficult’ COPD patient98, GPs perceive the management of 
COPD patients with worsening symptoms as particularly ‘serious’. 
 
Further, the patients’ stories revealed that, from their perspective, decision-making 
about the use of antibiotics and oral corticosteroids is a ‘serious undertaking’ (Patient 
study113). Yet, COPD patients seem to have a different risk perception than GPs. Instead of 
being most worried about further deterioration of symptoms, patients’ concerns seemed to 
focus on the self-treatment medications’ side effects, particularly the effect on their general 
future health. Many had also a quite strong, yet somehow diffuse, awareness that one should 
not take antibiotics unnecessarily as they could lose their effect in the future (Patient 
study113). Importantly, particularly for patients who experience a rather diffuse development 
of symptoms, such concerns seemed to contribute to hesitation and insecurity, eventually 
rejection of starting self-treatment without a confirmation from a doctor (Patient study113). 
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Previous studies have comparable findings, e.g. that COPD patients can be worried about the 
medications’ side effects79,88, and there is in fact a considerable body of literature on patients’ 
medication related concerns in general153-157. As I see it, patients’ treatment perceptions are 
not very present in the self-treatment debate. Davies et al., who as part of the overall 
PEXACO project explored clinicians’ views on self-treatment, found that clinicians assumed 
patients to rather overuse self-treatment medications for, for instance, minor colds71. 
Seemingly, the assumption that patients tend to overuse medications is quite common, as is 
the attempt to ‘conquer’ this with information, patient education and appeals to patients to use 
medicine ‘rational’. I would argue that the findings from the Patient study and the GP study 
indicate that some COPD patients deal more cautiously with antibiotics and oral 
corticosteroids than GPs. Certainly, it is not possible to say from our studies who makes the 
‘better’ treatment decisions in terms of medical accuracy. What I regard as quite concerning, 
however, is that patients’ concerns seemed sometimes quite exaggerated and could, in 
combination with uncertainty, result in hesitation to start treatment (Patient study113), a 
hesitation that may result in an unfavourable outcome. This suggests that patient education is 
still important, yet the focus of educational strategies should also be on treatment perceptions. 
Therefore, we suggested to include the Necessity-Concerns-Framework120 as a potentially 
useful theoretical framework for the theoretical foundations of the self-treatment concept83. It 
is an extension of Leventhal’s Common Sense Model of Illness Representations82, which is 
regularly brought up in the COPD self-management literature, and the extension highlights 
that patients’ can experience a “necessity-concerns-dilemma” when weighing up the personal 
need for treatment and the concerns about potential negative consequences120.  
 
Overall, as I interpret the findings from the GP study and the Patient study, both 
perceived the decision-making situation as somehow ‘risky’ or ‘serious’, yet the focus of 
GPs’ and patients’ concerns, and their risk rationality seemed to focus on quite different 
aspects of the overall phenomenon. Neither the GPs’ nor the patients’ risk perception and risk 
management approach may be regarded as rational or irrational, but reflect an individual 
negotiation of risk and uncertainty in a ‘real world’ context158. Importantly, risk management 
of individuals, which is informed by social relations, experience, emotions and intuition, may 
not match with policy intended, ‘desirable’ risk management that is often based on economic 
evaluations, standardisations and abstractions of risk158-160. When it comes to managing 
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COPD exacerbations, I see this mismatch reflected when looking at our findings in the light 
of the rationales that underlie the current ‘trends’/goals in care policies for COPD 
exacerbations (see Literature review). For instance, COPD patients’ medication related 
concerns and resulting hesitation seem contradictory to one of the major purposes of the self-
treatment concept that aims for early/prompt treatment initiation. Therefore, we argued in the 
Patient study that caution is recommended when assuming that introducing self-treatment of 
COPD exacerbations would ‘automatically’ result in early treatment initiation. Concerning 
GPs’ approach to deal with uncertainty and risk, there seems to be a contradiction between the 
precautionary decision-making approach to treatment and hospitalizations, and the overall 
policy goal to reduce hospitalization rates and ‘unnecessary’ use of antibiotics (and oral 
corticosteroids). Indeed, a ‘wait and see’ approach to treatment, and taking responsibility for a 
‘high risk’ COPD patient in primary care, may in many cases be out of a GPs’ ‘comfort zone’. 
However, the important question, then, would be how to overcome these 
controversies/tensions and work towards a common goal? It seems as if providing more 
information about how something should be done according to medical, economical or public 
health ‘rationality’ in guidelines, or self-treatment plans, is only helpful to a limited extent. 
For instance, when it comes to antibiotic prescribing in general, even though GPs’ may 
experience ‘prescribing against the evidence’ as uncomfortable, the rather abstract risk of 
bacterial resistance development seems less relevant to GPs’ decision-making161 than more 
concrete risks, of which the consequences may not only affect patients but also the GPs 
themselves162. In terms of self-treatment, it does not seem that more efforts in educating 
patients about the medical nature of COPD exacerbations and the pharmacological effect of 
antibiotics and oral corticosteroids can turn patients into more ‘effective’ self-treaters85. 
Focusing on and addressing potential tensions between different perspectives on risk and 
necessity for treatment seems, in my view, most promising to overcome decision-making 
based on ‘misunderstandings’. As an example, I want to refer to Altiner et al.’s study that 
showed the effectiveness of an interventional strategy focusing on doctor–patient 
communication and patient empowerment to reduce antibiotic prescriptions in primary 
care163. Comparable approaches may be worth considering for future interventions on the 




5.1.3 The relational dimension of decision-making 
The findings of the Patient study and the GP study suggest that management decisions for 
COPD exacerbations involve different actors within and across care sectors, and that the 
nature of the relationship between actors can have a considerable influence on the 
management of COPD exacerbations. Care relations can refer to the patient-physician 
relationship but also to relations in broader context, such as interprofessional relations and 
relations between care sectors. 
 
The patient-physician relationship 
The patient-physician relationship can be described as “the medium in which data are 
gathered, diagnoses and plans are made, compliance is accomplished, and healing, patient 
activation, and support are provided.”164. One could also describe it as the medium in which 
decisions are made.  
 
As described above, involving patients in the decision-making and considering their 
experiential knowledge emerged as a valuable resource for GPs (GP study121), particularly 
experience from patients with frequent COPD exacerbations and recurrent symptom patterns. 
This group of patients is, however, only a subgroup of patients, and not all patients may have 
similar experience (Patient study113). Moreover, we know from the literature on patient 
involvement/shared decision-making/patient empowerment that not all patients want to be 
involved in care decisions, and that involving patients successfully (e.g. in terms of patient 
satisfaction and health outcomes) in ‘real life’ care decisions depends on many interrelated 
factors165-168. As the participating GPs emphasized, involving patients into the decision-
making always encompasses balancing the patients’ knowledge with preferences that, even 
though important to consider, may not always serve medically appropriate management (GP 
study121). We know from the GP study that this balancing can be particularly difficult when 
GPs feel uncertain themselves. In terms of antibiotic prescribing, other studies have shown 
that GPs can feel pressured to prescribe, and for instance in order to preserve the relationship 
to patients, may give in to patients’ demands43,46,48. Also the clinicians’ perception of the 
patients’ expectations has been shown to strongly predict prescribing47. Importantly, as 
discussed above, COPD patients may not necessarily want prescriptions in the first place 
(Patient study113). Moreover, some of the patients’ narratives reminded us that the patient-
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physician relationship is first and foremost a care relationship, and that providing reassurance 
and comfort may be primary to a physician’s supportiveness (Patient study113,161. 
 
It was indeed the patients’ stories on help seeking that revealed the importance of a 
‘good’ patient-physician relationship to care, despite the fact that, or maybe because, these 
patients have got the opportunity for self-treatment. Even though our study suggests that the 
majority of patients liked the idea of self-treatment (Patient study113), i.e. providing a sense of 
security, Nici seemed right when emphasizing that “having action-plans is one thing, but 
putting them into practice is another story”61. Except the subgroup of patients that did not 
seem to experience difficulties with self-treatment, our findings showed clearly that medical 
uncertainty can be as present in the patients’ homes as in the GPs’ office (Patient study113). 
One could ask how patients can be able to differentiate between comorbidities and pure 
COPD exacerbations when such diagnostics are already challenging for GPs (GP study121). 
Indeed, it seemed as if in situations of uncertainty, including cases of treatment failure, even 
the most confident ‘self-treaters’ would have appreciated professional assistance (Patient 
study113). From a medical perspective and reasons of patient safety, it seems implicit that 
patients should contact their doctor when self-treatment is not working. Even though many 
self-treatment interventions provide patients with the opportunity to contact a case manager if 
needed68,169, it has been speculated that case managers can delay assessment by a healthcare 
professional61. Our findings can neither confirm nor reject this, but they indicate that the ‘help 
seeking part’ of self-treatment, particularly issues of trust and responsibility in the patient-
physician relationship, should be closer investigated. Indeed, our results showed that distrust 
in the doctor’s ability to help may make patients use the self-treatment opportunity to bypass 
unwanted encounters with doctors. Another help seeking pattern emerging from the patients’ 
stories was that patients may reject self-treatment except for emergency situations as they 
consider the expertise and responsibility for such ‘serious’ decisions should be in the hands of 
professionals. Or, insecurity regarding responsibility and feelings of obligation to succeed 
with self-treatment may result in hesitation to seek help when feeling uncertain (Patient 
study113). Comparable findings, i.e. that introducing self-management as care form can 
‘disturb’ the existing patient-physician relationship concerning views on what oneself or the 
other part is responsible for, have been made in a qualitative study on asthma self-
management170. Also Blakeman has raised concerns that introducing new means of healthcare 
might threaten patients’ established relation to healthcare professionals and become a barrier 
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to the implementation of these new care forms171. For COPD, ‘responsibility’ has often been 
linked to stigma and COPD being a self- inflicted disease, which has been found related to 
patients’ self-management behaviour172-175. Therefore, it might be particularly important in 
terms of COPD self-treatment to be aware that insensitive communication when giving self-
treatment instructions can lead to misinterpretations, e.g. increasing feelings of self-blame and 
rejection176. Perhaps, adapting the educational part in self-treatment interventions according to 
these relational/interpersonal aspects may be one key to more successful self-treatment 
interventions.  
 
Interprofessional relations and relations between care sectors 
According to the findings of the GP study, not only GPs and patients but also patients’ family 
members, other healthcare professionals and organizational/infrastructural factors are 
involved in shaping decisions (GP study121). The most important function of these other 
actors seemed to be the reduction of medical uncertainty and related concerns through sharing 
expertise and responsibility.  
 
For instance, GPs emphasized the advantage of collaborating with hospital-based 
physicians/hospitals with access to more advanced diagnostic technologies. Comparably, 
Risør et al.’s study on both GPs’ and pulmonologists’ views suggests that collaboration can 
help reduce uncertainty around comorbidities98. The primary reason for referring a patient, 
however, may not be diagnostics but the GPs’ - perhaps the patients’ - evaluation that the 
illness is too severe to justify treatment at home. As seen in the GP study, whether or not a 
patient finally is admitted depends not only on the GPs’/ patients’ evaluation, but also on the 
admitting physicians’ agreement that hospital treatment is necessary (GP study121). It seemed 
as if the GPs have had experienced difficulties with justifying referrals that were not based on 
objective clinical criteria but a more holistic evaluation based on tacit/situational/contextual 
knowledge grounded in the patient-physician relationship (GP study121). Hence, there was not 
only ambiguity about what counted as legitimate reason for hospitalization, but also regarding 
boundaries of responsibility. The challenges experienced by GPs seem to be grounded in 
cultural differences of the professions that may be based on “educational experiences and the 
socialization process that occur during training of each health professional”177. In the GP 
study, we argued that due to not speaking “the same language”72, referral decisions based on a 
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holistic evaluation might not match with more biomedical oriented treatment criteria applied 
in specialist care. In this regard, the imbalance of expertise in COPD guideline development 
committees, i.e. underrepresentation of primary care expertise (Guideline study112), may 
contribute to reinforce tensions in inter-professional relations. It may indeed be the cultural 
habits, assumptions and experiences that fill the existing gap of scientific/biomedical 
knowledge during the development of recommendations178,179. More clinical evidence would 
probably help to close the gaps regarding medical scientific knowledge, but may only help to 
a certain extent to close the ‘cultural’ gaps between professions and care sectors. Therefore, 
involving the expertise of all stakeholders in developing care standards should also include 
awareness of different professional cultures to improve implementation of care standards180 
and interprofessional collaboration177. 
 
Cultural barriers are only one of several structural and professional barriers to 
interprofessional collaboration181-183, and are not limited to cooperation between GPs and 
hospital-based physicians/pulmonologists. Discrepancies regarding the perspective on a 
condition’s severity, necessity for treatment and areas of responsibility can, for instance, also 
challenge collaboration between patients, informal caregivers and healthcare 
professionals184,185. This is, in my view, very relevant considering the findings from the GP 
study that emphasize the important role of informal caregivers and primary care services as 
‘security network’ for GPs to managing ‘high’ risk COPD patients (GP study121). We argued 
in the GP study that more important than the type of service or the ‘title’ of actors, such as 
‘nurse’ or ‘pulmonologist’, seems their function as ‘insurance’. Having this ‘insurance’ could 
attenuate consequences of wrong decisions through facilitating follow-up of patients in their 
homes and timely access to more advanced care if necessary (GP study121). Currently, 
intermediate care models, such as Hospital at Home, which provides “active treatment by 
healthcare professionals in the patient’s home for a condition that otherwise would require 
hospital care” 186, seem to be a type of service that holds the ‘security network’/’insurance’ 
function in today’s organization of COPD care. I would argue that the supportive and 
collaborative nature of a ‘security network’, i.e. to share expertise and responsibility among 
carers, could be a key component of such models. Also in terms of self-treatment, our 
findings have shown the importance of providing assistance and support, which is why I 
consider calls for a collaborative understanding of the self-treatment idea as reasonable187,188. 
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Considering that healthcare professionals can have concerns regarding patient safety when it 
comes to self-treatment71, understanding self-treatment as collaborative treatment may also 
have a positive effect on physicians’ will to implement self-treatment.   
 
5.2 Discussion of methods 
This part of the discussion can be regarded as an extension of the methods section that 
primarily addressed the ‘procedural’ aspect of the methods and how we used them. Here, I 
will discuss how the choice of methods and the way I applied them in the three studies have 
an impact on my results, and describe my strategies to ensure the credibility of my research. 
Moreover, I will address ethical considerations regarding the interview studies. 
 
5.2.1 The Guideline study: A systematic review of COPD guidelines       
The purpose of the Guideline study was to get an overview over the recommendations for 
treating COPD patients with exacerbations with antibiotics and oral corticosteroids. 
Moreover, by assessing aspects of guideline development, such as composition of guideline 
development committees, rigour of literature review and characteristics of the evidence 
underlying the recommendations, our aim was to evaluate the relevance of treatment criteria 
to a primary care setting. We conducted a rigorous and systematic search to get hold of COPD 
guidelines, but we might have missed guidelines published in other languages other than the 
ones included, and local guidelines used in different hospitals that may not be accessible 
through databases. If we, optimally, had included all existing COPD guidelines, we might 
have found slightly more diversity in treatment criteria, yet this we would have not altered the 
overall results. Assessing the quality of guideline development including the evidence 
underlying the recommendations was complicated by the different guidelines’ compositions 
and ways to present the development process, recommendations and links to evidence. 
Therefore, we might have got an impression of guideline development that is not similar to 
the probably very complex ‘real’ process of guideline development. That we did not use the 
AGREE II tool111 to its full extent is, in our view, reasonable as our main interest was in the 
relevance of treatment criteria to a primary care setting, and not in the overall guideline 
quality. The assessment of the evidence may be biased in terms of selection, as we, due to the 
different ways of presenting recommendations and evidence in the guidelines, only included 
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trials that were directly linked to a recommendation. However, according to the AGREE II 
tool, an explicit link between recommendations and evidence is an important quality criterion 
111. In order to strengthen our findings concerning applicability of existing evidence to a 
primary care setting, we added trials included in the latest Cochrane reviews about treating 
COPD exacerbations with systemic corticosteroids23 and antibiotics22 into our assessment. 
Overall, we argue, that our review enabled us to get an overview over the criteria on which 
the assessment and treatment of COPD exacerbations should be based on in primary care 
from an ‘EBM perspective’, and was useful to highlight challenges that reside within an 
evidence-based approach to managing COPD exacerbations. It is, however, important to note 
that our review only gives an ‘instant picture’ of guidelines and recommendations. Therefore, 
the validity and relevance of our findings may decrease as the understanding of COPD 
exacerbations and development of diagnostic means progresses, and new 
guidelines/recommendations are being released. 
 
5.2.2 Methodological rigour in qualitative research                                                                                    
In quantitative research, credibility of results is often evaluated by a set of criteria, e.g. 
validity and reliability, that refer to whether a method can measure what is intended to be 
measured (validity), and whether the method can reproduce the results (reliability), 
respectively189. In the qualitative research tradition, which is typically grounded on different 
ontological and epistemological assumptions than quantitative research (see Methodological 
considerations), it may be problematic to apply exactly the same quality criteria. 
Consequently, different sets of evaluation criteria have been proposed for qualitative research. 
Lincoln and Guba, for instance, suggested credibility, transferability, dependability and 
confirmability190, and Malterud relevance, validity, transferability and reflexivity1,191. 
According to Malterud, relevance refers to the usefulness of scientific knowledge in terms of 
its originality, and can apply to research questions, results, or to terms, concepts and 
methods1. Validity and transferability refer to whether the methods used investigate what one 
wants to investigate and to the degree to which the produced knowledge applies to another 
context than the actual study setting, respectively1,108. Overall, however, I understand that the 
underlying concern regarding the quality of qualitative interview studies lies in the 
researcher’s ability to make good choices and to conduct the research in a systematic way, 
based on reflection on the relation between him- or herself, reality, the methods and the 
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results. Reflexivity is also central to Stige et al.’s suggestion of an agenda to evaluate 
qualitative research116. They note that “the diversity of traditions that characterize research 
suggests that general checklists or shared criteria for evaluation are problematic”116, as “the 
practice of rule-based evaluation is only defensible when the study to be evaluated is based on 
a corresponding epistemological foundation”116. Reflexivity requires the researcher to 
critically question whether the steps undertaken are reasonable, defendable and supportive of 
what the researcher concludes108. Drawing on Stige et al.’s suggestion, I regard this 
discussion of methods as a “reflexive dialogue”116 that addresses the “challenges of producing 
rich and substantive accounts” and the “challenge of dealing with preconditions and 
consequences of research”116.  
 
5.2.3 The Patient study and the GP study: Interview studies                                                                                                                                
In the method section, I have presented the interview forms (semi-structured in-depths 
interviews and FGDs) and analytic method (thematic analysis) that were used in the Patient 
study and the GP study, respectively, and described briefly how I designed the studies, 
gathered the data and conducted the analysis (see Methods). Here, I want to discuss my 
choices regarding the methods used and explain how I tried to ensure trustworthiness of my 
results.  
The aim for this investigation (the qualitative part) was to explore the decision-making 
concerning management of COPD exacerbations from the perspective of those who make 
these decisions as part of their everyday life, in ‘real world’. Interviews are a good way to get 
insight into how people experience their “lifeworld”105, and as Kvale and Brinkmann describe 
it, “provide us with valid knowledge about our conversational reality”108. From this 
understanding, interview knowledge is produced rather than collected, and what we can learn 
from interview knowledge depends therefore on, among other things, the type of interview, 
the relation between the interviewer and interviewee, and the context in which the interview is 
conducted and analysed108. For the Patient study, the main interest was to explore COPD 
patients’ experiences and reasoning regarding a certain phenomenon, i.e. self-treatment. In 
order to get an ‘in-depths’ understanding of their reasoning, we chose individual semi-
structured interviews. FGDs, which were used for the GP study, are more dynamic in nature, 
and are more adequate to use when the study aim is to get a rather broad understanding of a 
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phenomenon192. While individual interviews are a dialogue between the researcher and the 
participant that allows, among other things, inviting the participant to elaborate his personal 
stories more in detail, FGDs involve several individuals who engage in the discussion. FGDs 
are typically more steered by the participants themselves. The group interaction characteristic 
of this interview form can stimulate and unravel opinions, which are less accessible in 
individual interviews, and gives the participants the opportunity to define themselves what is 
relevant or important within the topic of interest192. Overall, it is important to remember that 
the knowledge produced in the Patient study and in the GP study, is based on the participants’ 
narrations that reflect memories of past events. Therefore, the participants’ stories did not 
reproduce events as such, but provided a perspective of how the participants explain these 
events within their “social and political worlds”193. 
 
5.2.3.1 Patient study 
Before data collection, the researcher has to decide on which participants to include in the 
study. For the Patient study, we wanted to include patients from the ‘real world’, as my 
literature studies had uncovered that there is little knowledge about how self-treatment of 
COPD exacerbations is actually practiced by COPD patients that are not part of self-
management programs (see Literature review and Gaps of knowledge). Moreover, we wanted 
to include patients with mostly mild to moderate COPD, as it is probably these patients who 
are taken care of in primary care. Initially, we included patients with and without self-
treatment medications, which was due to an originally broader aim of the Patient study, i.e. 
focus on self-management of exacerbations in general and not only on self-treatment with 
antibiotics and/or oral corticosteroids.  As described in the ‘Method section’, we decided to 
narrow down the aim of the study and only focus on COPD patients’ experiences with self-
treatment. Subsequently, we recruited four more COPD patients who had self-treatment 
medications on stand-by. Overall, our sample varied in terms of gender, age, working status, 
civil status, residence and severity of COPD (see Table 1). The heterogeneous sample and an 
inductive analytic strategy enabled us to get insight into a different self-treatment strategies 
and explanatory frameworks193. In terms of sampling, ‘saturation’ is another central feature 
regarding the credibility of qualitative research194. In the Patient study, this was an issue from 
the data collection phase to publishing, mostly due to the changes in the study aim and 
inclusion criteria. The reviewers, for instance, had problems to accept that 12 participants 
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were sufficient to obtain saturation. Morse notes that, in order to reach saturation, all aspects 
of the phenomenon must be explored both in broadness and depths, and that the data from 
different participants share essential characteristics194. Especially since I had interviewed 19 
COPD patients in total, of which seven broadened my understanding of the phenomenon 
rather than simply replicating or adding up on the number of stories, I felt that my 
understanding of the phenomenon was comprehensive, and that the categories I developed 
were consistent. Even though I agree that it is debatable whether I should have included the 
seven interviews with COPD patients without self-treatment medications in the whole 
analytic process, I would argue that my dataset was both “adequate” (large enough for 
replication to occur and be noted) and “appropriate” (those interviewed were experts in the 
phenomenon of interest)194. Saturation, however, is not only depending on the number of 
interviews, or participants. Rather, the researcher needs to be skilled and prepared, for 
instance through theoretical awareness and knowledge about relevant literature, to ask the 
‘right’ questions to the participants during the interview and to the data during the analytic 
process194.  
 
In terms of interviewing, i.e. data collection, I interviewed most of the participants in 
their homes. This added a certain contextual understanding about how the participants lived. 
The two participants I interviewed at UiT The Arctic University of Norway felt indeed more 
‘unknown’, or ‘anonymous’ to me. However, for qualitative interview studies, it is not only 
the physical context of the interview situation that influences knowledge production, but also 
the relational context, i.e. what is “happening between the researcher and the participant”108. 
The latter relates for instance to the questions the researcher asks, and how he or she asks 
them. According to Malterud, if we want to gain knowledge about something we did not 
know before, it is important to be not too steering in the interview situation, but let the 
participants’ version of the phenomenon of interest unfold on the participants’ premises1. I 
opened the interviews, after an introduction of myself, the study and the nature of a research 
interview, with an open question about what comes in the participant’s mind when thinking of 
the term ‘COPD exacerbation’, and what they associate with it. The purpose of this was to 
find a common ground with the participants in terms of what composes a ‘COPD 
exacerbation’, or using Malterud’s words, “to shift focus from the voice of medicine to the 
voice of the lifeworld”1,105. However, when reading the results, it should be kept in mind that 
the participants may in some cases not have talked about exacerbations in a medical sense, but 
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about illness episodes resulting in actions such as self-treatment or help seeking. Moreover, 
physicians might, for instance, be used to ‘clinical interviewing’, which differs from a 
research interview in terms of what type of knowledge the interviewer wants to obtain and for 
which purpose1. It was in some cases challenging to balance letting the participants tell their 
story and keeping track of my own agenda. Especially the participants who had not received 
self-treatment medications seemed often more concerned with other aspects of living with 
COPD than with how to deal with exacerbations.  Yet, it was important to have an open mind 
to the participants’ own agenda1. For instance, in retrospect, I believe that the many stories 
that addressed health contacts and relationships to healthcare professionals (not only in terms 
of treatment of exacerbations) helped me to understand self-treatment as a relational, 
collaborative activity. 
 
Writing down some reflective thoughts directly after the interviews and discussing 
‘how it went’ with my supervisor helped me to establish a “metaposition”1, which I hope also 
improved my interview skills gradually during the data collection process.                                                                                                      
Moreover, during the data collection phase, I became already aware of certain topics that 
seemed overall relevant, and could start to develop a theoretical understanding about these 
topics through literature studies. The transcription of qualitative research interviews can also 
be regarded as part of the analytic process, as it serves the researcher to get an overview over 
the whole dataset and develop first thoughts about important topics. Due to time restrictions, I 
only transcribed one patient interview myself and hired an external person for the job. I 
obtained oral consent from my participants for that someone else could hear their stories 
(though anonymised), instructed him carefully, and had regular meetings with him to resolve 
any ambiguity regarding the meaning of phrases. Overall, I think that outsourcing the 
transcription did neither bring considerable disadvantages regarding the results of the study, 
nor any important ethical dilemmas. 
 
We chose an inductive and semantic approach to analysis for both the Patient study 
and the   GP study. A deductive and latent approach might have shed light on other aspects 
and challenges than those my ‘version’ highlights. Other researchers with other backgrounds 
but similar analytic strategy may also have chosen to highlight other aspects. The researcher’s 
background and theoretical stance influences which questions that researcher asks to the data, 
and what the researcher sees in the data. As the anthropologists Andersen and Risør stated, 
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interviewing people to find out what they do and why requires “reflexivity on social context, 
the nature of verbal statements and the situatedness of the interview encounter.”193. By trying 
to ask questions to the data that address preconditions for and consequences of the 
participants’ actions instead of only looking at the actions themselves, and by looking for 
actions/explanations that were unexpected, surprising or seemed contradictory, I tried to avoid 
simple, naïve explanations of causal relations. Another strategy to improve the analysis of 
qualitative data and validity of analytic constructs is to triangulate the analysis, e.g. to involve 
several researchers or peers in the interpretation of data195. I applied this strategy through 
discussion of my codes and ideas for themes with others, for instance my supervisors or peers. 
As also described in the Methods section, I tried to enhance my understanding of the data 
through regarding my thoughts in the light of existing theoretical concepts in a kind of 
‘explorative manner’, i.e. trying to apply different concepts (such as Attachment Theory119 
and the Necessity-Concerns-Framework120) on my analytic categories to find controversies 
and inconsistencies in my constructs. Overall, through reflection, discussion and reading I 
developed an understanding that self-treatment of COPD patients is as much a question of the 
patient-physician relationship, trust and responsibility as it is of clinical signs, clear symptoms 
and medical knowledge. It might be particularly difficult for healthcare researchers from a 
medical tradition to not relating medical scientific knowledge to rational behaviour, and other 
types of knowledge to irrational and erroneous beliefs and behaviours. It was therefore, I 
would say, particularly helpful to work closely together with a medical anthropologist (Mette 
Bech Risør) who challenged my own interpretations through discussions and suggestions of 
relevant theoretical concepts. 
 
 
5.2.3.2 GP study 
For the GP study, the interviews were already conducted when I engaged in the research 
project. As for the Patient study, it is important to note that through interviewing people about 
what they did in the past, and why, we can only know something about what people think 
they do, and not what they are actually doing. In order to gain knowledge about what GPs 
‘really’ do in clinical problem-solving situations, and to get insight into the cognitive 
processes during the decision-making, other data collection methods, such as the Think aloud 
Method that produces data on what comes to the participants’ mind during a problem solving 
task196, may have been more appropriate. Sampling was done purposefully in all participating 
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countries, yet through different ‘logistics’ in the sampling/recruitment (see Table 3). The GPs 
in our sample had different backgrounds in terms of clinical experience, gender and 
workplace, healthcare system, local organization of healthcare system and sociocultural 
background. The heterogeneity in the sample enabled us to identify essential features, 
common themes and concerns across the individual cases103. Yet, we acknowledged that this 
focus on common views produced in a focus group setting limits the direct applicability of 
our findings to a specific setting. 
In terms of the sampling strategy through personal contacts and networks, many participants 
of one group knew each other. This might have created a safe setting for the discussion, but 
could also have been a barrier to critical and open-minded comments. Regarding the 
moderation, one should remember that even though the moderators in the respective countries 
were trained beforehand in the FGD method, most were novices of the method and their 
individual moderation style has probably influenced the interview course.  
 
For the GP study, as I did neither conduct nor transcribe the FGDs, these early analytic 
phases were not, or less, relevant as in the Patient study. Therefore, my analysis started with 
thorough repeated reading of the transcripts and eventually writing memos about initial 
thoughts. During the first coding, I tried to code, among other things, clinical signs and 
examinations that the GPs use for hospitalization and treatment with antibiotics and oral 
corticosteroids, but realized soon that this was not ‘working’. In retrospect, I would say, this 
was because I tried to code the data with a medical/clinical view. It took many discussions, 
memo writing, re-thinking many of my initial codes and engaging with more sociologically 
grounded concepts on medical practice (such as Donald Schön’s “The Reflective 
Practitioner”197), to change my ‘analytic view’. My analysis of the data challenged also 
another pre-assumption I obviously had, i.e. that GPs always act as ‘perfect agent’ for the 
patient. Leaving this view behind opened up for further development of the analytic 
categories that encompassed not to solve the problem (decision-making), but also to define 
the problem, the “problem-setting”197. 
 
As Andersen and Risør emphasized, social responses, as for instance a management 
decision of a GP, may often be implicit, taken for granted, and may therefore be difficult for 
people to verbalize193. Beckstead et al. reported that physician have rather modest insight into 
their decision-making, i.e. that their tacit policies (what they do) differ from their stated 
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policies (what they think they do)198. For the participants in the GP study, I could sometimes 
‘sense’ this difficulty for the GPs to express the logic behind their actions - their professional 
routine - in the data. Moreover, I experienced the interpretation of the GPs accounts within 
their sociocultural background challenging, as my contextual understanding was, at least for 
most of the countries, limited to the organization of healthcare systems and did not encompass 
cultural variations regarding, for instance, patient-involvement, and relationships to political 
institutions (even though these variations were apparent in the data). There could have been 
‘hidden’ meanings in the GPs’ accounts that were not made explicit during the discussion as 
all the participants including moderator were from the same sociocultural context and may 
have understood them without further explanation. Also, working with translated transcripts 
carried the risk that phrases/ideas did not reflect their actual meaning. We tried to resolve 
these issues by keeping up communication between the researchers in the participating 
countries. 
Being critical to how to express, and conceptualize the participants’ accounts is also 
important when it comes to reporting findings. In this regard, I want to comment on terms that 
I used to describe the ‘easiness’ of a treatment decision in both the Patient study and the GP 
study. Patients and GPs could perceive decisions as straightforward or as difficult, but one 
should be cautious to assume that easy decisions are appropriate decisions. For instance, it 
might be easy to always prescribe/take oral corticosteroids when experiencing worsening 
dyspnoea, yet as we have argued previously, relying on such general criteria may lead to 
overtreatment (Guideline study112)/uncritical use of the medications (GP study121/Patient 
study113). Moreover, from decision-making theory, we know that decisions which are 
perceived more difficult are eventually more deliberated and thought through76. Decisions 
may be perceived as ‘easy’ if made via mental short cuts, e.g. heuristics or pattern-
recognition199,200, and these rather subconscious decision-making processes are related to a 
number of biases and may result in irrational decisions201.  
Finally, some reflections about transferability or to which degree my findings are 
generalizable to other contexts than the actual study setting. Generalizability of qualitative 
research may be more controversial than in a quantitative research tradition. One the one 
hand, one could say that qualitative research aims to add an understanding of human 
experience through studying particular cases. Such cases are always contextually embedded 
and may therefore be difficult to generalize. On the other hand, qualitative research that 
60 
 
succeeds with revealing an understanding of a phenomenon on a higher abstraction level, or a 
more theoretical understanding of a phenomenon, may indeed be suitable for extrapolation202. 
Overall, the aim of research, regardless of methodology, must be to produce knowledge that is 
useful beyond the study setting, yet without claiming universal generalizability191. Sampling, 
sampling strategies and the participant characteristics are considerably influencing what the 
researcher can conclude with, and to which settings the findings are relevant191. We applied 
similar sampling strategies in the Patient study and the GP study in terms of aiming for varied 
samples regarding participant demographics (see Tables 1 and 3) within a group of persons 
that can be regarded as experts in the phenomenon of interest. Our samples in both interview 
studies included social actors from ‘real world’ clinical practice as opposed to actors that 
belonged to an ‘artificial’ reconstruction of the ‘real world’ as found in scientific experiments 
or randomized trials. For both the Patient study and the GP study, I would argue, our findings 
therefore add a new and valid dimension to the phenomenon of self-treatment of COPD 
exacerbations, and management of COPD exacerbations, respectively, grounded on ‘real 
world’ experiences. The aim of both studies was to describe and conceptualize a phenomenon 
using an inductive and semantic approach to data analysis (see Methods). Through abstraction 
and conceptualization of the data, which included to describe and enrich analytic themes with 
existing theoretical terms and within existing theoretical concepts, I belief that we were able 
to broaden the relevance and transferability of our findings to overall phenomena/concepts. 
For the Patient study, these concepts related mainly to patients’ health and illness behaviour 
and help seeking behaviour, and for the GP study to concepts such as medical uncertainty, 
medical decision-making and care concepts (GP study121). Moreover, I would argue that our 
findings are relevant to different settings. They can inform both clinical practice in routine 
care (for both patients and healthcare professionals) and future research (research concepts, 
research problems and study designs). I consider our findings also relevant to health 
policies/political decision-makers in a reciprocal way, as they provide empirical knowledge 
from - and about - those social actors that healthcare policies aim to influence, and about how 
these social actors may actually be influenced by healthcare policies. 
 
5.3 The ethics of interview studies                                                                                       
Consequences and potential harm for the participants, including voluntary participation, 
always have to be considered in scientific inquiry. In interview studies, such harms may occur 
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during the very interview situation, particularly when topics are highly sensitive108. The topics 
for the Patient study might not appear highly sensitive from an objective point of view, yet 
could be for the participants. I experienced once that a participant did not want to talk about a 
certain topic, which I of course respected. I have great respect for their openness and will to 
share intimate details of their lives and appreciated their engagement during the interviews. 
All but two participants invited me to their homes. I did not feel that their motivation to 
participate derived from the gift coupon they received as compensations to their time and 
effort. Rather, it seemed as if they were motivated by being helpful and by contributing with 
their knowledge, and most of them seemed to enjoy that someone was interested in hearing 
their story. 
   
The interviewer, who is the “main instrument to obtain knowledge”108, has a crucial 
role in a qualitative inquiry, both to ensure quality of the scientific knowledge and in terms of 
showing morally responsible research behaviour108. Much of the researcher’s interviewing 
skills have to be acquired through experience108. Even though I had read about and 
theoretically thought-out interviewing, I surely lacked experience as a novice researcher. For 
instance, I experienced it sometimes difficult to balance stopping a participant when drifting 
too far off the interview’s topic without a feeling of insulting him or her. Moreover, even 
though my professional background as medical doctor and general practitioner trainee was 
helpful in the sense that I knew the diseases, treatments and pathways through the healthcare 
systems many participants were talking about, it could be difficult to not let my relation to the 
participant become a “pseudo-therapeutic”108 doctor-patient relationship. For instance, it was 
challenging to know how far I should go in terms of answering the participants’ questions 
about their health problems or explaining medical issues they had obviously misunderstood 
(for instance regarding usefulness of antibiotics or side effects of oral corticosteroids). 
Moreover, I had to remind myself several times to keep neutrality when participants talked 
about negative experiences with the healthcare system and particular doctors I was in two 
occasions able to recognize just from the participants’ stories. I tried to resolve these 
challenges through openness and explanation about the nature of a research interview, and 





For the GP study, the fact that some participants knew each other might have created a 
safe setting for in-depth discussions. However, to reflect on one’s own decision-making, or to 
disclose insecurity regarding own practice may have caused discomfort. Hopefully, the 
moderators were able to dissolve such potential discomfort and provided the opportunity for 
de-briefing subsequent to the discussions.  
 
Research should be relevant to science and society, which I think the study aims fulfil 
given the great burden of COPD and knowledge gaps regarding management of the illness in 
primary care. Through publishing my findings in open access journals, presentation at a 
congress and an article a medical ‘newspaper’203, I was able to give something back to the 
scientific and medical community. COPD patients and GPs might benefit indirectly through 
improvements in patient care, or through more awareness and improvement of their working 
conditions, respectively. 
  
The participants of both studies received a small remuneration, which should show our 
thankfulness for them giving us their time and contribution to our research. This may have 
contributed to a certain ‘willingness’ to take part in the study. However, we did not consider 
such a small amount to have contributed to a selection bias, or an ethical issue, e.g. that those 
who were in need of money were particularly eager to participate, or did only participate 
because of the remuneration.  
 
  
6 Conclusion and future perspectives  
 
Conclusion                                                                                                                                   
This thesis aimed to explore decision-making concerning COPD exacerbations in primary 
care, focusing on treatment with antibiotics and/or oral corticosteroids, help seeking and 
hospitalization. The investigation started with a systematic review of current COPD 
guidelines and underlying evidence to assess how COPD exacerbations should be treated in 
primary care according to the best available evidence. Furthermore, we explored decision-
making of patients and GPs, focusing on self-treatment with antibiotics and/or oral 




The findings of the three papers lead to the conclusion that it is difficult to make treatment 
decisions based on a purely medical interpretation of symptoms, signs and diagnostic tests. 
Medical uncertainty plays a major role in the management of COPD exacerbations, and 
worries about the consequences of ‘wrong’ decisions emerged as a strong driver of decision-
making. Patients’ and GPs’ perceptions of  ‘risk’ may affect treatment and hospitalization in 
ways that are conflicting with overall care goals, e.g. low hospitalization rates, rational use of 
antibiotics/oral corticosteroids and early self-treatment of exacerbations. Clinical and personal 
knowledge about patients, and patients’ own experiential knowledge from having lived with 
COPD and from previous exacerbations can be a valuable resource for interpreting the 
clinical picture. Experiential knowledge seems also important for patients to feel confident in 
self-treatment, which is why patients with recurrent exacerbations and clear symptom patterns 
seem most suitable for this care form. Self-treatment can play an important role for some 
patients. Yet it should be regarded as supplement to regular care to ensure timely help by a 
GP or other healthcare professional when needed. Instructing patients in self-treatment should 
encompass potential medication-related concerns, and making a self-treatment plan should 
include a ‘plan’ for help seeking. A well-functioning primary care infrastructure seems 
important, as it could provide assistance for patients in their homes and provide a sense of 
security among GPs, eventually reducing precautionary decisions while ensuring patient 
safety. Access to more advanced diagnostic technology and to specialist expertise seems also 
important to reduce GPs’ uncertainty related worries. However, different rationalities on risk 
and on what counts as ‘appropriate’ decision, as well as unclear areas of responsibility, can be 
barriers to successful collaboration between different healthcare professionals, as well as 
between healthcare professionals and patients. 
 
Overall, the findings of this thesis support an integrative and collaborative approach to 
management of COPD exacerbations. The heterogeneous, versatile and often individualized 
nature of COPD exacerbations requires a flexible framework to decision-making that 
integrates both medical knowledge and other types of knowledge that are grounded in human 
experience and relationships. Such an integrative understanding of knowledge may guide 
future clinical research and guideline development in considering primary care evidence and 
expertise from primary care stakeholders and patients to a larger extent. It may also facilitate 
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collaborative management of COPD exacerbations that allows for sharing expertise and 




The findings of the Guideline study uncovers a need for more research in the primary care 
setting that includes patients with milder illness and comorbidities. In the future, when the 
biomedical understanding of COPD and its exacerbations will improve, it might be possible 
to identify reliable biomarkers or other clinical indicators to better target treatment with 
antibiotics and oral corticosteroids. It would be interesting to gain a better understanding of 
how patients’ symptom experience is related to pathophysiological processes, to results of 
clinical examination, point of care testing, as well as to the effect of antibiotics and oral 
corticosteroids. Such knowledge could strengthen primary care of COPD patients with 
exacerbations, and could also inform future COPD guidelines, including recommendations for 
choosing patients for self-treatment. Overall, it should be remembered that COPD 
exacerbations can indeed be severe, and that relocating care responsibility towards primary 
care, and also towards the patients themselves, may entail a larger number of patients with 
more severe illness in primary care. This might require an adaption of organization and 
competence in primary care that can ensure monitoring of patients in their homes, and, for 
self-treatment, to provide enough resources to develop and implement patient education. It 
will be important to clarify the role of different types of healthcare facilities/professionals, 
such as primary care teams, and of informal carers, in self-treatment, help seeking and 
treatment support in homes, both in an overall context but also in local healthcare contexts. In 
the future, telehealth solutions will certainly play a more important role for both self-
treatment and regular care, particularly for patients who find it difficult to reach the GPs’ 
office due to living in rural areas or because of physical disabilities. 
However, such innovative care strategies should not replace but rather supplement regular 
care, which, after all, rests on the relationship between the involved persons. In this regard, it 
seems useful to organize primary healthcare in a way that enables the development of long-
term relationships between patients and healthcare professionals. Moreover, 
interprofessionalism and communication skills will be similarly important as biomedical 
understanding of illness in the education of future healthcare professionals.  
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Closing remark                                                                                                            
This investigation is set in a part of the world where COPD patients have usually access to 
advanced medical technology and medicines. In other parts of the world, the developing 
world for instance, COPD may be equally prevalent, yet the preconditions to providing care 
may be less favourable. Moreover, in this part of the world, there may exist a considerable 
gap of knowledge about how to best possibly prevent and treat COPD. We are talking about 
the global burden of COPD, but our efforts to improve care for these patients seem to me 
often rather local than global. Some years ago, for instance, I was attending a conference on 
respiratory diseases, and it was striking to see the different premises on how COPD care is 
based in a global context. That is, while researchers in one parallel session were concerned 
with improving health outcomes with new medicines, those in another parallel session 
discussed how to provide electricity to people in Sub-Saharan Africa in order to prevent 
respiratory illness from biomass fuelling. I am not saying that one discussion was better or 
more important than the other was, and both are probably relevant in their respective 
contexts. However, in my mind, these two parallel sessions reflected a health inequity that is 
still reality and probably tragic for many COPD patients and other people. Inequities in 
health are, however, not only a concern in the developing world; they might only be more 
severe and therefore more ‘visible’ than health inequities in the Western societies. With this 
closing remark, I want to remind the research community of its power and, in my mind, 
obligation, to shed light on and work towards an eradication of health inequity in both a 
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- Kan du fortelle om deg selv, hva du fyller dagene dine med og hvordan du bor, 
hva du jobber med?. 
- Når ble KOLSen oppdaget? Hvilken behandling for du? Har du noen andre 
sykdommer du må ta medisiner for? 
 
Pasientens forståelse av, reaksjoner (emosjonelt, kognitiv) på og atferd ved en forverring? 
- Hva betyr «KOLS forverring» for deg? Hvordan kaller du det? 
- Hvordan vet du at det er KOLSen og ikke noe annet? 
- Hva får det deg til å tenke/føle?? 
- Hva får de tankene/følelser deg til å gjøre? 
- Hva synes du er det verste med en forverring? 
- Hvordan går det med jobb/sosialt liv/samliv/humør når du har en forverring? 
- Hva gjør du for å takle du utfordringene?  
- Hva eller hvem hjelper deg mest når du har en forverring? 
- Hvem søker du råd hos? 
- Hva tror du kunne hjelpe deg enda mer? 
Pasientens holdninger til og erfaringer med egenbehandling og beredskapsmedisiner? 
- Hvem ga deg medisinene? 
- Hvorfor har du fått medisinene? 
- Kan du fortelle om veiledning du har fått i hvordan du skal tolke symptomer og 
bruke medisiner? 
- Var det noe spesielt du tenkte? 
- Hvordan føltes det å få medisinene? 
- Hva sa legen skal du gjøre når du får en forverring? 
- Når skal du bruke antibiotika/prednisolon? 
- Har du fått noe skriftlig også? Kan jeg få se det? 
- Synes du det er lett å forstå? 
- Kan du fortelle om en situasjon hvor du har brukt antibiotika/steroider? 
- Var det vanskelig å vite om du skulle ta medisinene? 
- Hvis aldri brukt: har du noen gang vurdert å bruke de?  
- Hva gjorde at du bestemte deg for å bruke de/ikke bruke ? Hva gjorde du i stedet? 
- Ville du anbefale til en venn eller mann/kone å ha beredskapsmedisiner? 
- Hjalp medisinene deg? 
- Hva ville du gjøre hvis du ikke blir bedre av å ta medisinene? 
 
Hvordan påvirkes opplevelse av behandling i helsevesenet?  
- Kan du fortelle om en situasjon hvor du kontaktet legen da KOLSen ble verre? 
- Hva spesielt gjorde at du tok kontakt? 
- Hva gjør legen når du kommer pga KOLS? 
- Synes du han/hun gjør en god jobb? 
- Stoler du på legen din? 
- Hva er annerledes på sykehuset? 
- Hvem liker du best å kontakte når du trenger hjelp med KOLS? 
- Hva kan fastlege/lege på sykehuset hjelpe deg med? 
- Har du mindre behov for å ta kontakt med lege nå? 
- Synes du der vanskeligere å kontakte legen nå? 
- Hvor viktig er legen for deg når det gjelder behandlingen KOLS (forverringer)? 
- Har behandlingen du får forandret seg etter at du fikk medisinene? 
- Hvis du kunne ønske deg noe fastlegen gjør annerledes, hva ville det være? 
 
Hvordan påvirkes opplevelse av mestring, ansvar, autonomi, trygghet? 
- Hva er fordeler og ulemper med å behandle seg selv? 
- Blir det lettere for deg å leve med KOLS? 
- Har du mer kontroll på KOLS nå? 
- Føler du at du har mer ansvar for din helse? 
- Var det noen gang ubehagelig eller utrygg å måtte bestemme selv?  
- Er det noen personer eller et eller annet som støtter deg? 
Er det noe annet du har lyst å fortelle og som vi ikke har snakket om enda? 
 
 
